NewzIntel.com

Category: COVID-19 Vaccine

  • MIL-OSI USA: Senator Hassan Slams RFK Jr. as a Dangerous Rubber Stamp for Donald Trump

    US Senate News:

    Source: United States Senator for New Hampshire Maggie Hassan
    “When was it that you decided to sell out the values you’ve had your whole life in order to be given power by President Trump?”
    WASHINGTON – At a Senate Finance Committee hearing today, U.S. Senator Maggie Hassan (D-NH) slammed President Trump’s Secretary of Health and Human Services nominee Robert F. Kennedy Jr. for being “willing to sacrifice your values, your knowledge, if President Trump tells you to do that,” specifically highlighting Mr. Kennedy’s flip-flopping on issues such as reproductive freedom.
    Click here to watch Senator Hassan question RFK Jr. on his refusal to put the health and well-being of the American people above his allegiance to Donald Trump.
    Senator Hassan began by highlighting Mr. Kennedy’s record of spreading dangerous vaccine misinformation. Then, Senator Hassan highlighted his rapidly shifting positions on the right for women to make their own reproductive health care decisions. “Mr. Kennedy…You have clearly stated in the past that bodily autonomy is one of your core values. The question is do you stand for that value or not? When was it that you decided to sell out the values you’ve had your whole life in order to be given power by President Trump?” said Senator Hassan when pressing him during the confirmation hearing today on his shifting positions.
    “What you’re telling us is if President Trump orders you to take action to make it harder for women to get direly needed health care, you’ll follow his order. If Mr. Trump, as he did yesterday, orders a halt on Medicaid payments that are essential for taking care of people with disabilities all around this country, you’re going to follow that order. Because you are willing to sacrifice your values, your knowledge, if President Trump tells you to do that. That to me is unacceptable in a Secretary of Health and Human Services,” Senator Hassan concluded.

    MIL OSI USA News –

  • MIL-OSI USA: Schatz: Senate Must Stop RFK Jr.’s Dangerous Nomination

    US Senate News:

    Source: United States Senator for Hawaii Brian Schatz
    WASHINGTON – Ahead of confirmation hearings this week on the nomination of Robert F. Kennedy Jr. to be Secretary of the Department of Health and Human Services, U.S. Senator Brian Schatz (D-Hawai‘i) again urged his colleagues to vote no, highlighting Kennedy’s pivotal role in causing a measles outbreak in Samoa in 2019, which resulted in over 5,700 people getting infected and 83 people – mostly young children – dying.
    “The unique threat that Robert F. Kennedy Jr. poses to our country really cannot be overstated. And now it is up to us, the 100 members of the United States Senate, to deny him the opportunity to use America as one big test lab for bygone diseases,” said Senator Schatz. “I understand my Republican colleagues are facing a lot of pressure from within. But this nomination is not actually like the others. Look at what he’s done. Time and time again, he’s abandoned every physician’s first principle: Do no harm. He has caused disease. He has caused pain. He has caused death.”
    Senator Schatz continued, “The vote we’re going to be taking on this nominee is much more than your party or mine. It’s life or death. And I promise you, if this person is confirmed, it will not age well: not in a Republican primary, not in a Democratic primary, not in your family, not in your community. Nowhere will an RFK ‘aye’ vote age well. This person is going to cause disease across the United States. I urge a no vote.”
    Schatz likened Kennedy’s desire to run a “natural experiment” to see how people in Samoa would fare against the measles without protection to the Tuskegee experiment, in which the United States Public Health Service purposefully withheld treatment from men with syphilis in order to study the disease’s progression. The first person to raise the alarm about the cruelty of the experiment in 1965 was Schatz’s father, Dr. Irv Schatz.
    “I never thought that 60 years later, I’d be standing in the very body that passed legislation in response to that shameful period, arguing against confirming someone who wants to replicate that experiment at scale. That’s what RFK Jr. wants to do. He wants to use Americans as lab rats in a national experiment. And if it means bringing back the measles or the mumps or rubella or polio, so be it. That is the cost of doing business, as he sees it,” said Senator Schatz.
    A transcript of Senator Schatz’s remarks is below. Video is available here.
    If you heard your doctor say, ‘there’s no vaccine that is safe or effective.’ Or ‘there are much better candidates than HIV for what causes AIDS.’ Or ‘school shootings started happening with the introduction of Prozac and other drugs.’ If your physician said any of those things to you, you would look for a new physician.
    And yet, this week, my colleagues on the Senate Finance Committee and Health Committee are going to consider the nomination of someone who’s not only said all those things – and more. But if confirmed, he would be responsible for the health and well-being of the entire nation.
    The unique threat that Robert F. Kennedy Jr. poses to our country really cannot be overstated. And now it is up to us, the 100 members of the United States Senate, to deny him the opportunity to use America as one big test lab for bygone diseases. And I want to explain what I mean by that. He thinks that FDA trials are not enough to determine the efficacy of a vaccine. And so he’s suggesting that we use placebo in the population. What does that mean? Something might save someone’s life, and something might be essentially a sugar pill. But you don’t get to know. There are international conventions against this approach. The Tuskegee experiments conducted by the United States Public Health Service were universally rejected, and the Congress banned this approach because you cannot withhold lifesaving care from anyone.
    Now, saying crazy things doesn’t seem to be disqualifying for a nominee these days, I understand. But it’s not just that he said crazy things or holds deranged views. It’s that he has acted on them. And I want everybody to listen to what exactly happened in Samoa – not 20 years ago, not ten years ago, but in 2019. While he was chairman of the anti-vaccine group, he flew to Samoa because he sensed an opportunity to exploit people’s hesitations about taking the measles vaccine.
    People were understandably worried after an accident… involving improperly prepared vaccines killed two babies. It was a tragedy, and it was a costly mistake, but not a reason to abandon the measles vaccine altogether. But RFK sought to make people more afraid. He discouraged people from taking the vaccine because he wanted to run a “natural experiment.” To see how people fared against the disease without protection. To see how people fared against the disease without protection? This guy is up for HHS, Health and Human Services? This guy just wants to see what would happen if we didn’t give people the lifesaving protection that they need. He literally flew to the other side of the planet to turn people’s fears into a data collection opportunity.
    For some context here. Samoa is a small country and had a population of around 200,000 people at the time. People knew each other and word got around fast. A Kennedy was in town saying a thing. And so it was no small thing that this man from America, with the last name Kennedy, pretending to be a health expert, was there peddling all kinds of lies to prevent people from getting a lifesaving vaccine.
    And those lies spread fast. Vaccination rates plummeted, and within five months, Samoa had a measles outbreak. 5,700 people were infected with the measles. 83 people died. Almost all of them were children. That was the conclusion of Mr. Kennedy’s natural experiment. Children died. This isn’t some ancient history I’m digging up here. This was less than six years ago, and it is alarmingly reminiscent of one of the darkest chapters in our country’s history with the Tuskegee experiment.
    For 40 years, beginning in 1932, the United States Public Health Service ran an experiment with 600 black men in Alabama. The majority of them had syphilis, and the objective was to “observe the disease process.” And so even when penicillin became the standard of care in 1947, the men who needed that treatment, who could have been given lifesaving care, were denied penicillin. Researchers did nothing as men died and they went blind because they wanted to see how the disease would develop. A natural experiment.
    It took a young doctor, not long out of medical school, who read about the study in a medical journal and couldn’t believe his eyes. He could not understand how the United States government had come to view these poor sharecroppers as expendable, as subhuman. He thought about the Hippocratic Oath, that he and every doctor like him had sworn to. What happened to, “first, do no harm”?
    And so, not knowing what else to do, but knowing he was risking a whole lot by speaking out, he wrote to the study’s authors. And I want to read a bit of what he wrote: “I’m utterly astounded by the fact that physicians allow patients with a potentially fatal disease to remain untreated when effective therapy is available. I assume you feel that the information which is extracted from the observation of this untreated group is worth their sacrifice. If this is the case, then I suggest the United States Public Health Service and those physicians associated with it in this study need to reevaluate their moral judgments in this regard”.
    The man who wrote that letter, and was the first, and for a long time, the only person to sound the alarm about the depravity of the Tuskegee experiment was my dad, Dr. Irv Schatz. It’s one of the many reasons that he’s my hero. But I never thought that 60 years later, I’d be standing in the very body that passed legislation in response to that shameful period, arguing against confirming someone who wants to replicate that experiment at scale. That’s what RFK Jr. wants to do. He wants to use Americans as lab rats in a national experiment. And if it means bringing back the measles or the mumps or rubella or polio, so be it. That is the cost of doing business, as he sees it.
    I understand my Republican colleagues are facing a lot of pressure from within. It’s a new administration, and you want to give them deference. An executive, generally speaking, gets to have their team. But this nomination is not actually like the others, even if you don’t want to take Mr. Kennedy’s words so literally, maybe you think he’s just wondering aloud, look at his actions. Look at what he’s done. Time and time again, he’s abandoned every physician’s first principle: Do no harm. “I shall do by my patients as I would be done by. And I shall minimize suffering whenever a cure cannot be obtained.” That’s part of the oath every medical student takes at graduation before they can practice. And yet, the person nominated to lead the country’s entire health system has consistently done the exact opposite. He has caused disease. He has caused pain. He has caused death.
    And so the vote we’re going to be taking on this nominee is much more than your party or mine. It’s life or death. And I promise you, if this person is confirmed, it will not age well: not in a Republican primary, not in a Democratic primary, not in your family, not in your community. Nowhere will an RFK ‘aye’ vote age well. This person is going to cause disease across the United States. I urge a no vote.

    MIL OSI USA News –

  • MIL-OSI USA: Welch Questions RFK Jr.’s Lack of Experience, Character During Confirmation Hearing for Secretary of Health and Human Services 

    US Senate News:

    Source: United States Senator Peter Welch (D-Vermont)
    Welch highlights RFK Jr.’s lack of plans to fix broken health care system 
    WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.) today raised concerns about the character and fitness of Robert F. Kennedy Jr., President Trump’s nominee to be the Secretary of Health and Human Services (HHS), to lead HHS’ ten public health service agencies and three human services agencies. Senator Welch also expressed concern about the lack of concrete plans by the Trump Administration and Mr. Kennedy to lower health care costs for Vermont families. 
    Watch the exchange between Senator Welch and Robert F. Kennedy Jr., President Trump’s pick for Secretary of Health: 
    Read excerpts of Senator Welch’s questioning below: 
    “This is not just about a debate about vaccines. It’s a debate about the qualifications, experience, and priorities as to the person that will head Health and Human Services. And it’s not just about what your answers are today or what the questions are.” 
    “The question I fundamentally have is whether your willingness to disrupt and maybe break rules is going to be dangerous and destructive.”  
    “There’s incidents that do, I think, concern the question of whether the stability is there to be in charge of this major organization. That’s compounded by my concern that you don’t have any experience managing a large organization. That you don’t have any experience in government. So, those are things that have to be taken into account…” 
    ••• 
    “I’ve seen nothing coming out of the Trump Administration–and I’ve seen nothing coming out of your advocacy–that is going after what is a rampant abuse by the insurance companies and overcharging people and not doing the job. 
    “It’s a broken health care system. We spend the most and get the least. And I think there should be collective anger about on this by both sides. Because all of our people are dependent on that health care system.” 

    MIL OSI USA News –

  • MIL-OSI United Nations: Israel’s new laws banning UNRWA already taking effect

    Source: United Nations 4

    Peace and Security

    Israeli legislation banning the UN agency for Palestine refugees, UNRWA, is due to enter into force in the coming hours, bringing fundamental changes to its operations in the Occupied Palestinian Territory, according to the agency and Palestinians they serve in Gaza who spoke with UN News on Wednesday.

    Soundcloud

    If implemented, the two new laws passed in October will simultaneously prohibit Israeli authorities from contacting UNRWA and ban the agency from operating in war-ravaged Gaza and East Jerusalem and the West Bank, according to UNRWA spokesperson Jonathan Fowler.

    As such, poised to change are Israel’s role as the occupying power and the work of the UN General Assembly-mandated agency known since 1949 as the backbone of humanitarian aid assisting nearly six million Palestine refugees today.

    Check out UN Photo’s essay What UNRWA Built here.

    © UNRWA

    The war in Gaza has seen an unprecedented number of attacks on UN premises and staff. (file)

    Evacuation and relocation

    Israel as the occupying power is responsible for issuing visas to international staff from humanitarian organizations like UNRWA, whose headquarters in occupied East Jerusalem comprise a compound protected by the 1946 Convention on Diplomatic Relations.

    © UNRWA

    UNRWA has been called the backbone of humanitarian assistance in war-ravaged Gaza.

    The Knesset legislation has yet to come into force but is already impacting UN operations in the region.

    Israel has shortened all visas for UNRWA’s international staff to expire on Wednesday, which “is tantamount to being evicted” or declared persona non grata, Mr. Fowler said.

    As such, UNRWA’s international staff at the East Jerusalem office had to evacuate and relocate to Amman, Jordan earlier in the day. Office equipment and vehicles have been moved out, and efforts are continuing to digitise its archives.

    National staff will remain in East Jerusalem, but they face risks, including upcoming demonstrations by Israeli protestors, Mr. Fowler said. During the Gaza war, the compound had faced security issues, including arson attacks and violent protests.

    UNRWA had to comply with Israeli orders due to visa requirements despite East Jerusalem being recognised as occupied territory under international law, he added.

    Will UNRWA shut down completely?

    UNRWA’s mandate has remained the same for decades and it will not be ceasing all operations, said Mr. Fowler. It is unique as a working model that has provided core services such as healthcare and education to refugees and their descendants in line with its General Assembly-approved mandate.

    The agency also provides services to Palestinians in Jordan, Lebanon and Syria.

    “UNRWA remains absolutely committed to stay and deliver,” Mr. Fowler said.

    “We will not stop. We’re not bowing down to this. But, we do know that the practical impacts, the uncertainty mean that our operations could be substantially affected.”

    © UNRWA

    UNRWA and partners begin the second round of the polio vaccination campaign in Gaza in 2024. (file)

    Backbone of aid in Gaza

    Up to the current fragile ceasefire, Israeli forces killed more than 47,000 Palestinians – according to local health authorities – and 270 UNRWA staff members in Gaza. Yet, despite challenges, agency staff in Gaza continue to operate, providing essential humanitarian aid, Mr. Fowler said.

    Over the first three days of the 19 January ceasefire, UNRWA provided food for one million people and one million blankets.

    Indeed, the UN agency is responsible for over half of deliveries inside the Gaza Strip and over half the aid coming in.

    The ceasefire has allowed UNRWA to scale up aid, but the situation remains precarious, he stressed.

    © UNRWA

    Aid is delivered to Gaza as Palestinians return to their homes during the ceasefire.

    Impact on services

    The Israeli laws could halt all UNRWA operations in Gaza, East Jerusalem and the West Bank, affecting schools, healthcare centres and other services, Mr. Fowler explained.

    Some Palestinians in Gaza are worried at the prospect of losing UNRWA, including Iman Hillis, who is currently staying in an UNRWA school with her family.

    “We will have nothing to eat or drink, and this will affect us greatly,” she told UN News. “All the people will be destroyed and will not have food, water or flour.”

    International response amid ‘biggest fears’

    UNRWA supporters, UN Member States and UN officials have pressed Israel to reverse course up to the last minute. However, there is concern about the precedent this situation could set for other UN operations worldwide, Mr. Fowler said.

    The current situation is as unique as the agency itself. Israel’s ban is unprecedented. Never before has a UN Member State tried to undo the mandate of a UN organization.

    ‘We’re at the 11th hour’

    “We face the risk of this becoming an example, which would then eventually morph into some kind of new normal,” Mr. Fowler said.

    In other places around the world, that “new normal” is a “very, very nightmarish scenario”, he warned.

    “The multilateral system is not perfect, but it’s the system that we have, and this is a unilateral blow against multilateralism,” he said.

    “We’re at the 11th hour. We all have to continue efforts to convince Israeli authorities to at least freeze this decision or void the laws completely. Our biggest fear is there is no Plan B.”

    Why can’t other aid agencies just take over?

    Uniquely, the UN General Assembly makes the decisions on UNRWA and how and where it operates.

    “No other agency has the scale and depth to do what we do,” Mr. Fowler said.

    However, under international humanitarian law, the occupying power is responsible to assure the wellbeing of the population under occupation, he added.

    “By voiding our mandate, the Israeli officials who have promoted this need to think hard about the fact that if there’s any Plan B, it’s on them,” he said.

    Soundcloud

    How will Israel’s role change?

    As the occupying power, Israel is and has been responsible for all services to the populations living in Occupied Palestinian Territory since it seized the areas in 1967.

    An agreement in 1967 between Israel and UNRWA recognised the UN Palestine relief agency and its General Assembly-mandated tasks serving Gaza, East Jerusalem and the West Bank.

    With the new legislation that, in effect, cancels that agreement, Israel continues to be responsible as the occupying power, including for all public services.

    As such, Israel will need to absorb the cost. UNRWA’s annual budget runs at about $1 billion every year.

    UN News

    Over 20,000 displaced Palestinians are taking shelter in a UNRWA school in Gaza.

    What is UNRWA?

    Since 1950, the UN Relief and Works Agency for Palestine Refugees (UNRWA) has contributed to the welfare and human development of Palestine refugees, defined as “persons whose normal place of residence was Palestine during the period 1 June 1946 to 15 May 1948, and who lost both home and means of livelihood as a result of the 1948 war”.

    © UNRWA

    Humanitarian aid delivered to Gaza.

    • The agency operates in Jordan, Lebanon, Syria, Gaza and the West Bank, including East Jerusalem. Established by a UN General Assembly resolution, UNRWA is funded almost entirely through voluntary contributions from UN Member States.
    • UNRWA has long faced misinformation and disinformation, including about its staff and operations. This has intensified since the war in Gaza began on 7 October 2023.
    • An example is the claim that the UN agencies that deliver humanitarian assistance in crisis zones across the globe would be better placed to do the work currently carried out by UNRWA.
    • In fact, UNRWA’s established infrastructure – the agency directly manages critical public-like services (schools, health centres, social protection), relying on 30,000 staff members, most of them Palestine refugees – and its cost-effectiveness have no equivalent elsewhere in the UN.
    • Find out more about the work UNRWA does here.

    MIL OSI United Nations News –

  • MIL-OSI USA: At Hearing, Warren Slams RFK Jr. for Dangerous Conflicts of Interest, Profiting From Anti-Vaccine Conspiracies

    US Senate News:

    Source: United States Senator for Massachusetts – Elizabeth Warren
    January 29, 2025
    Kennedy answers raise fresh questions about his ethics agreement
    Kennedy could profit from anti-vaccine lawsuits he can influence as Health Secretary 
    Warren: “Kennedy can kill off access to vaccines and make millions of dollars while he does it…Kids might die, but Robert Kennedy will keep cashing in.”
    Round 1 Questioning (YouTube) | Round 2 Questioning (YouTube)
    Washington, D.C. – At a hearing of the Senate Finance Committee, U.S. Senator Elizabeth Warren (D-Mass.), Ranking Member of the Senate Committee on Banking, Housing, and Urban Affairs and member of the Senate Finance Committee, questioned Mr. Robert F. Kennedy Jr., nominee for Secretary of Health and Human Services (HHS), about his dangerous conflicts of interest and record of profiting from anti-vaccine conspiracies. 
    Mr. Kennedy has made nearly $2.5 million in referral fees from the law firm Wisner Baum, in connection with lawsuits against vaccine makers. Mr. Kennedy receives a 10% contingency fee in these cases if the plaintiffs win, and his ethics agreement indicates he will continue to receive these payments even if he is confirmed as HHS Secretary. However, during his confirmation hearing, Mr. Kennedy initially appeared to agree to not accept any compensation from lawsuits against drug companies while serving as HHS Secretary, stating, “Well, I will certainly commit to that while I’m Secretary.” He then backtracked and did not clearly commit to ending this arrangement — through which he can profit off of anti-vaccine lawsuits even if he is confirmed as HHS Secretary. 
    If Mr. Kennedy does maintain his financial stake in anti-vaccine lawsuits, he will have a serious conflict of interest. Senator Warren highlighted seven ways Mr. Kennedy could benefit financially from anti-vaccine lawsuits and increase his payouts, including: 
    Publishing anti-vaccine conspiracies on government letterhead to influence juries;
    Appointing anti-vaccine people to the CDC vaccine panel;
    Opening vaccine manufacturers to lawsuits by removing vaccines from special compensation programs;
    Making more injuries eligible for compensation even with no causal evidence;
    Change vaccine court processes to make it easier to bring junk lawsuits to get vaccines pulled from the market; and 
    Turn over FDA data to his connections at law firm Wisner Baum, for their use in lawsuits. 
    Senator Warren also asked Mr. Kennedy if he would take responsibility for more than 80 deaths in Samoa after Mr. Kennedy spread anti-vaccine conspiracies in the country. Mr. Kennedy refused to take responsibility. 
    Transcript: Hearing to consider the nomination of Robert F. Kennedy, Jr., of California, to be Secretary of Health and Human ServicesSenate Committee on Finance January 29, 2025
    Senator Elizabeth Warren: Thank you, Mr. Chairman. Mr. Kennedy, I want to start with something that I think you and I agree on: Big Pharma has too much power in Washington. You’ve said that, President Trump asked you to, “clean up corruption and conflicts.” Sounds great. You’ve said you will “slam shut the revolving door” between government agencies and the companies they regulate. That also sounds great.
    So here’s an easy question: will you commit that when you leave this job, you will not accept compensation from a drug company, a medical device company, a hospital system, or a health insurer for at least four years—including as a lobbyist or board member? 
    Mr. Robert F. Kennedy, Jr., nominee for Secretary of Health and Human Services: Can you just repeat the last part of the question? Can I commit to what?
    Senator Warren: Sure, you’re not going to take money from drug companies in any way shape or form?
    Mr. Kennedy: Who? Me? 
    Senator Warren: Yes. You. 
    Mr. Kennedy: I’m happy to commit to that.
    Senator Warren: Good, that’s what I figured. I said, it’s an easy question to start with. And I think you’re right on this question – 
    Mr. Kennedy: I don’t think any of them want to give me any money, by the way.
    Senator Warren: Let’s keep going. You are right to say yes because every American has the right to know that every decision you make as our number one health officer is to help them—not to make money for yourself in the future.
    So, I want to talk more about money. I’m looking at your paperwork right now. In the past two years, you’ve raked in $2.5 million from a law firm called Wisner Baum. You go online, you do commercials to encourage people to sign up with Wisner Baum to join lawsuits against vaccine makers. And for everyone who signs up, you personally get paid, and if they win their case, you get 10% of what they win. So, if you bring in someone who gets $10 million, you walk away with a million dollars. 
    Now, you just said that you want the American people to know that you cannot be bought, your decisions won’t depend on how much money you could make in the future, you won’t go work for a drug company after you leave HHS. But you and I both know there’s another way to make money. 
    So, Mr. Kennedy, will you also agree that you also won’t take any compensation from any lawsuits against drug companies while you are Secretary and for four years afterwards?
    Mr. Kennedy: Well, I will certainly commit to that while I’m Secretary. But I do want to clarify something because you make me sound like a shill. I put together that case. I did the science day presentation to the judge on that case to get it into court, the docket hearing – 
    Senator Warren: Mr. Kennedy, it’s just a really simple question. You’ve taken in $2.5 million, I want to know if you will commit right now that not only will you not go to work for drug companies, you won’t go to work suing the drug companies and taking your rake out of that while you are Secretary and for four years after.
    Mr. Kennedy: I will commit to not taking any fees from drug companies while I’m Secretary. I –  
    Senator Warren: No, I’m asking about fees from suing drug companies. Will you agree not to do that?
    Mr. Kennedy: You are asking me to not sue drug companies, and I’m not going to agree to that – 
    Senator Warren: No. You can sue drug companies as much as you want. 
    Mr. Kennedy: I am not going to agree to not sue drug companies or anybody.
    Senator Warren: So, let’s do a quick count here of how, as Secretary of HHS, if you get confirmed, you could influence every one of those lawsuits. Well, let me start the list.
    You could publish your anti-vaccine conspiracies, but this time on U.S. government letterhead – something a jury might be impressed by. 
    Mr. Kennedy: I don’t understand that.
    Senator Warren: You could appoint people to the CDC vaccine panel who share your anti-vax views and let them do your dirty work.  
    You could tell the CDC vaccine panel to remove a particular vaccine from the vaccine schedule.
    You could remove vaccines from special compensation programs, which would open up manufacturers to mass torts.
    You could make more injuries eligible for compensation even if there’s no causal evidence. 
    You could change vaccine court processes to make it easier to bring junk lawsuits.
    You could turn over FDA data to your friends at the law firm, and they could use it however it benefitted them.
    You could change vaccine labelling.
    You could change vaccine information rules. 
    You could change which claims are compensated in the vaccine injury compensation program. 
    There’s a lot of ways you can influence those future lawsuits and pending lawsuits while you are Secretary of HHS, and I’m asking you to commit right now that you will not take a financial stake in every one of those lawsuits so that what you do as Secretary will also benefit you financially down the line.
    Mr. Kennedy: I will comply with all the ethical guidelines. 
    Senator Warren: That’s not the question. You and I—you have said repeatedly—
    Mr. Kennedy: You are asking me—Senator, you’re asking me not to sue vaccine—pharmaceutical companies.
    Senator Warren: No, I am not. My question is: stop enriching yourself.
    Look, no one should be fooled here. As Secretary of HHS, Robert Kennedy will have the power to undercut vaccines and vaccine manufacturing across our country. And for all his talk about “follow the science” and his promise that he won’t interfere with those of us who want to vaccinate our kids, the bottom line is the same: Kennedy can kill off access to vaccines and make millions of dollars while he does it. 
    Kids might die, but Robert Kennedy can keep cashing in. 
    Mr. Kennedy: Senator, I support vaccines, I will—I support the childhood schedule, I will do that. The only thing I want is good science, and that’s it.
    Senator Warren: How about then saying you won’t make money off what you do as Secretary of HHS?
    Chair Mike Crapo: Before we go to Senator Tillis, I think it would be important for me to make it very clear that Mr. Kennedy has gone through the same Office of Government Ethics process as every single other nominee in the Finance Committee this year and in previous administrations. In addition to listing his assets, including the items that you’ve identified, he has signed an ethics letter that has been reviewed by the Office of Government Ethics concerning any possible conflict in light of its functions and the nominee’s proposed duties. And we have a letter from the Office of Government Ethics that he has complied completely with all applicable laws and regulations governing conflicts of interest.
    Senator Warren: Mr. Chairman, point of information here: have we had a single nominee come through who’s made two and a half million dollars off suing one of the entities that it would be regulating and plans to keep getting a take of every lawsuit in the future? Have we had that before?
    Chair Crapo: I haven’t reviewed the past documentation of every other nominee’s financial interests, and so no. But I know that every single time we get a nominee, their financial interests are attacked. That’s why we have the Office of Government Ethics. That’s why they’ve reviewed everything that’s in his record, and that’s why he has even—I think, and I don’t know that I want to ask him to get into it—but he has listed his assets and has gone through a discussion of the responsibilities under our ethics laws and is complied with all of those requirements.
    Round 2
    Senator Warren: Thank you, Mr. Chairman. Mr. Kennedy, I want to ask about your role in a 2019 measles outbreak in Samoa. In July 2018, two children died immediately after receiving a measles vaccine that nurses had mistakenly mixed with a muscle relaxant. The nurses get charged with manslaughter, but the vaccination rates go down. 
    I asked you about this in my office. You told me flatly that your visit to Samoa had nothing to do with vaccinations. We now know that’s not true. I have the documentation. You met with the Prime Minister, you talked about vaccinations. You met with an anti-vaccine influencer who described the meeting as “profoundly monumental for this movement.” 
    So what happens? Vaccinations go down. There’s a measles outbreak, and children start dying, but you double down. You didn’t give up just four days after the Prime Minister declared a state of emergency. 16 people already dead. You sent a letter to him promoting the idea that the children had died not from measles but from a “defective vaccine.” You launched the idea that a measles vaccine caused these deaths. 
    You are a very influential man. In fact, you are called the leader of the disinformation dozen. UNICEF and WHO, the World Health Organization, investigated this. They say the claims are false. It is not biologically possible what you claimed, and yet, ultimately, more than 70 people died because they didn’t get vaccines. 
    So my question is, do you accept even a scintilla, just even a sliver of responsibility for the drop in vaccinations and the subsequent deaths of more than 70 people? Anything you’d do differently?
    Mr. Kennedy: No, absolutely not. After the—there were two incidents in which children died in 2015 and again in 2018. 2015, it was from the measles vaccine. That’s what the New Zealand General Hospital found. The government of Samoa banned the measles vaccine after 2018. I arrived in July of the next year, after the ban had been in place for a year, and the measles—
    Senator Warren: Mr. Chairman, understanding that you wanted to hold this to a minute, and then I don’t get to present all the facts and documentation I’ve got. How about if we just decide to make entries for the record on exactly what the record shows about Mr. Kennedy’s participation? And I think he’s answered the yes or no question. He takes no responsibility. 
    Chair Crapo: Senator Warren, we will do that. And Mr. Kennedy, and to all the senators, every senator knows that following this hearing, they will be able to ask you questions off the record, and you will be able to put answers back onto the record. So please give that answer. I apologize that we’re shutting you off for giving a full response right now.

    MIL OSI USA News –

  • MIL-OSI Security: Papua New Guinea Resumes Radiotherapy, Starts Brachytherapy Services with IAEA Support

    Source: International Atomic Energy Agency – IAEA

    Staff at Angau Memorial Hospital in Lae, Papua New Guinea, celebrate the installation of the new brachytherapy machine used to treat gynaecological and other cancers. (Photo: Angau Memorial Hospital)

    After nearly a decade of inactivity, Papua New Guinea’s only radiotherapy machine re-started operations six months ago with support from the IAEA, giving renewed hope to thousands of cancer patients in the country.  

    This month, radiation medicine services at Angau Memorial Hospital received a boost with the start of brachytherapy, a critical procedure in the treatment of cervical cancer.  

    “This milestone represents a significant advancement in our cervical cancer treatment capabilities, offering more precise and localized therapy options to improve patient outcomes,” said Athula Kumara, medical physics expert at Angau Memorial Hospital, the facility that received the IAEA support.  

    Located in the city of Lae, Papua New Guinea’s shipping hub in the north, Angau is the country’s second largest hospital, catering for 675 000 people in the Morobe Province and serving as a regional referral hospital for 1.9 million residents. 

    The improved service is important as cancer remains a major public health issue in the country, with a burden of over 12 000 new cases and more than 7000 deaths every year, according to 2022 IARC figures. Breast, cervix uteri, as well as lip and oral cancers are the most frequent among women.  

    Brachytherapy is a form of internal radiotherapy in which sealed radioactive sources are placed inside or near a tumour, delivering high doses of radiation directly to the cancer while sparing surrounding healthy tissues. The procedure is a key component of radiation treatment for gynaecological cancers, but it can also be used to treat prostate, breast, soft tissue sarcomas, some head and neck tumours, and skin cancers.  

    The brachytherapy equipment was installed in late 2024 at Angau and started services this month. The first patient, a woman with cervical cancer, underwent external beam radiotherapy last year and is now receiving brachytherapy treatment as a boost.  

    The installation of the brachytherapy machine follows previous IAEA assistance in re-establishing radiotherapy at Angau. Services were discontinued in 2016, severely limiting options for cancer patients in the country. Many were referred abroad, but few could afford it. “Some travelled to Manila for treatment, but these cases were rare due to the high cost of travel and treatment,” Kumara said.   

    In 2023, an imPACT review carried out by the IAEA in collaboration with the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) recommended to urgently reestablish radiotherapy services in the country.  

    Through its technical cooperation and human health programmes, the IAEA supported the hospital in replacing the radiotherapy machine’s radioactive source and provided advice on the acquisition of the new brachytherapy unit. Radiotherapy started again in mid-August 2024, and Angau has since been treating around 50 patients per month on average, with hundreds more registered for treatment. “Treatment has been very successful, and we have seen many patients recover significantly after undergoing therapy,” Kumara added. 

    A key pre-requisite for the upgrade in radiation medicine has been  training medical physicists. “These highly specialized health professionals ensure optimal equipment performance and maintain high-quality, safe treatment procedures,” said Daniel Berger, medical physicist in the IAEA’s Division of Human Health who led recent technical missions to build local capacity in the country. “Their expertise enables precise dosimetry, planning and dose delivery while ensuring equipment and clinical processes meet international standards for effective patient care,” he explained.   

    Medical physicists also provide technical guidance for infrastructure improvements, collaborating closely with regulatory authorities to licence and deploy nuclear and radiation medicine equipment. “Their work ensures that radiotherapy services can meet the growing demand for cancer care, ultimately helping to improve patient outcomes and advance healthcare standards,” Berger added.    

    Radiotherapy is one of the main pillars of cancer treatment, along with surgery and chemotherapy. In 2022, the IAEA launched the Rays of Hope initiative to support countries in increasing access to this life-saving treatment. Since becoming a Member State in 2012, Papua New Guinea has received IAEA support to strengthen radiation safety, including for the management of radiation sources for medical use, and to build the required capacity to expand cancer diagnosis and treatment.  

    While progress has been made in advancing cancer care, Kumara highlights that early diagnosis and treatment provision remain a challenge. “Patients arrive at very late stages of their cancer, often with extensive masses. By the time they seek treatment, the cancer has already spread, making it more difficult to achieve optimal outcomes,” he said. “One of our key goals moving forward is to increase awareness, particularly in remote areas where access to healthcare is limited.”  

    Cervical cancer is the fourth most common cancer in women globally, with around 660 000 new cases in 2022. About 94 per cent of the 350 000 deaths caused by cervical cancer in the same year occurred in low- and middle-income countries, driven by inequalities in access to vaccination against the human papillomavirus (HPV), responsible for 95 per cent of all cervical cancers, as well as screening and treatment services.  

    In many countries, January is Cervical Cancer Awareness Month, supporting efforts to promote HPV vaccination for prevention and early diagnosis and treatment of precancers, which greatly improve prospects for cure.   

    MIL Security OSI –

  • MIL-OSI Global: Is no amount of alcohol safe? Understanding risks and public health guidelines

    Source: The Conversation – Canada – By Scott Lear, Professor of Health Sciences, Simon Fraser University

    While it may be true that there is no safe level of alcohol consumption, are alarmist statements a good motivator for health messaging, or is there danger to using them? (Shutterstock)

    The United States surgeon general recently called for a warning of cancer risk on alcohol labels. And I agree. But the discourse that has come out in the media, by health professionals and health influencers, has been alarmist and a disservice to informing the public on the real cancer risks associated with alcohol.

    I’m a professor in Health Sciences at Simon Fraser University and I study how behaviours relate to the disease. I also write a blog on the role health behaviours play in your health.

    Alcohol and cancer risk

    The surgeon general’s comments follow reports from the World Health Organization and Canada’s Guidance on Alcohol and Health, both of which state there is no safe amount of alcohol you can consume.

    This has been repeated by health professionals, those in public health and on social media, where health influencers have described alcohol as a toxin.

    But are these alarmist statements a good motivator for health messaging, or is there danger to using them?

    Statistically, your risk for cancer goes up from the very first sip of alcohol. That doesn’t mean you will get cancer from drinking alcohol, it just means your chances increase. And as you drink more alcohol, your chances further increase. It’s like betting in roulette: the more numbers you bet on, the more likely you are to win. Or in this case, lose.

    Out of 800 women, one drink per week will result in two additional women getting breast cancer.
    (Shutterstock)

    However, what’s lost in this messaging is how much this risk is. Based on Canada’s Guidance on Alcohol and Health, having one drink per week increases a women’s risk for breast cancer by 1.8 per cent. Approximately one in eight women will develop breast cancer in their life. Therefore, out of 800 women, one drink per week will result in two additional women getting breast cancer. Having one drink per day increases the risk seven-fold. These are real people who might otherwise not get breast cancer if they abstained from alcohol.

    While saying no amount of alcohol is safe is true, this can apply to a lot of common activities. In Canada, there are approximately 300 pedestrian deaths per year. Each day, on average, five Canadians die in motor vehicle accidents.

    While these numbers are much lower than the number of people who die from cancer each year, it would also be accurate to say there is no amount of walking or driving that is safe. Despite this, people will continue to cross the street and people will continue to drive. But this illustrates the challenge in informing the public about risks and changing behaviour.

    Fear in public health messaging

    The use of fear in public health messaging should only be used if there’s an effective solution. In the case of alcohol, there is: abstinence.
    (Shutterstock)

    The use of fear in public health has a long history. But measuring the effect of these campaigns is hard. Graphic images are used on tobacco products to scare people away from smoking. Carefully controlled studies indicate they increase health awareness but may have limited effect on smoking. However, similar graphic images on bottles of sugar-sweetened beverages in controlled studies has been shown to reduce consumption.

    During the COVID-19 pandemic, fear was at the forefront of public health efforts to control the spread of SARS-CoV-2. Indeed, the use of fear in public health messaging seemed to be quite an effective tool in ensuring behavioural compliance in pandemic measures. Community interviews of parents showed fear was at the root of both getting their children vaccinated (fear of the disease) or not (fear of the vaccination).

    The use of fear in public health messaging should only be used if there’s an effective solution. In the case of alcohol, there is: abstinence. But the use of fear should also be commensurate with the risk, otherwise it risks having people tune out.

    This may be particularly problematic when previous guidelines stated beneficial effects of moderate drinking and current guidelines on alcohol state one to two drinks per day is acceptable. Instead, the public may be best served by communicating the risk in terms the public understands, such as how many more people will get cancer from drinking.

    Alcohol should have a warning label on it

    Alcohol consumption in Canada is on the decline. In 2022, alcohol consumption decreased by 1.2 per cent compared to 2021. And in 2023, 54 per cent of Canadians reported having no alcohol over the previous week, with younger Canadians drinking less than their older counterparts. These trends are similar in the United States.

    More than 40 countries have a warning label on alcohol (although far fewer mention cancer), but Canada and many European countries are not included. They should be. Alcohol is a highly addictive substance that can destroy the lives of those addicted to it and those around them. It impairs judgment and accounts for dozens of deaths per year from drinking and driving.

    Pregnant women drinking alcohol also increase their risk of their child having fetal alcohol spectrum disorder. Alcohol is also a drug you can overdose from.

    Warning labels on alcohol are a good step to reduce health risks, as long as they are clear and informative.

    Scott Lear receives funding from the Canadian Institutes of Health Research and Hamilton Health Sciences, and has received funding from the Heart and Stroke Foundation, Novo Nordisk, and the Robert Wood Johnson Foundation.

    – ref. Is no amount of alcohol safe? Understanding risks and public health guidelines – https://theconversation.com/is-no-amount-of-alcohol-safe-understanding-risks-and-public-health-guidelines-247883

    MIL OSI – Global Reports –

  • MIL-OSI United Kingdom: Over 3,000 Westminster residents supported to live healthier lives in 2024 through the Healthy Communities Fund | Westminster City Council

    Source: City of Westminster

    The Healthy Communities Fund (HCF) is a three-year initiative established in January 2024 to support organisations in the VCS to deliver culturally competent targeted health interventions in Westminster’s most deprived areas. 

    • Since its launch in January 2024, the Healthy Communities Fund has reached over 3,000 participants across Westminster with an average of 126 activities delivered per week. 
    •  The £5 million fund aims to support Voluntary and community sector (VCS) organisations to deliver culturally competent health interventions to prevent health conditions worsening or developing in the first place.  
    • Fund recipients ‘Middle Eastern Women’s Society’ helped participants to lose weight healthily, improve blood pressure and lower blood sugar levels through targeted health interventions.  

    The £5 million fund is part of the council’s wider prevention agenda and is a direct result of collaboration with residents and VCS partners. Fund recipients receive training commissioned by the council’s Public Health team to embed health promotion and health interventions by trusted organisations who know their communities well. While the fund aims to increase the capacity of these organisations, the training aims to provide sustainability so that fund recipients can continue to support community members for a long time.  

    In the last year the fund has helped to reach over 3,000 regular participants through an average of 126 activities per week.  

    Thanks to the incredible progress made by organisations funded by the HCF, the council has seen tangible health outcomes including weight loss, improved blood pressure and increased screening and vaccination uptake. 

    Fund recipients, Middle Eastern Women’s Society (MEWSO), delivered interventions with the support of the HCF aimed at improving physical health through healthy cooking classes, walking groups, and establishing peer support networks. As with all recipients, MEWSO’s interventions were delivered in response to identified health needs to ensure that they are targeted and relevant to the community they intend to reach.  

    Identified needs included support for residents with physical disabilities, translating traditional dishes into healthier recipes and difficulties with keeping physically active outside of fitness classes. With MEWSO’s support participants are being equipped with tools and knowledge to look after their health – the offer has become so popular that it now operates with a waiting list.  

    Aman Zanoon, the project manager at MEWSO said:

    Since we launched our healthy cooking classes on Church Street, the response has been overwhelmingly positive. The sessions became so popular that we now have a waiting list of women keen to join. To manage this, we rotate participants weekly, with 12 women in each class, ensuring fairness and access for everyone.

    One of the highlights of the project has been our recipe book, which till now contain 31 Middle Eastern dishes, presented in both traditional and healthier versions. Beyond the cooking, these classes have Inspired broader changes in our participants’ lives. Many women have formed walking groups, shared progress and more healthy snacks and recipes in a WhatsApp group.

    For example, Mayada, one of our participants, has lost 4kg over six months and has stabilised her blood pressure, while Najwa has reported a 2kg loss. Many others have shared similar successes, demonstrating that this initiative is more than just about cooking—it’s about life-changing improvements.

    Deputy Leader and Cabinet Member for Adult Social Care, Public Health and Voluntary Sector, Cllr Nafsika Butler-Thalassis said: 

    It’s amazing to see the progress that the Healthy Communities Fund has made in just one year. 

    We set up this fund in the council to increase the capacity of local grassroot community organisations because we know that they are best placed to serve the community, and we want to support them to increase their impact.

    To address health inequalities, it is essential to engage communities in activities they find interesting and enjoyable  which have wider benefits, touching not only on healthy eating and physical activity but also on mental health and reducing isolation.

    Further training will be rolled out in 2025 to ensure trusted organisations can continue to deliver commissioned services in the future, focusing on mental health, diabetes and hypertension.

    The Healthy Communities Fund provide free activities designed to meet the needs of the local community. It is part of our #2035 initiative to promote healthy living in the borough.

    MIL OSI United Kingdom –

  • MIL-OSI Canada: Governments of Canada and Saskatchewan Invest in Livestock and Forage Research

    Source: Government of Canada regional news

    Released on January 29, 2025

    Today, Canada’s Minister of Agriculture and Agri-Food Lawrence MacAulay and Saskatchewan’s Minister of Agriculture Daryl Harrison announced $6.9 million to jointly support livestock and forage-related scientific research in Saskatchewan in 2025, combined with co-funding from industry partners for a total of $7.2 million.

    The investment is part of Saskatchewan’s 2024-25 Budget of $37 million for agriculture research and is delivered through the province’s Agriculture Development Fund (ADF) under the Sustainable Canadian Agricultural Partnership (Sustainable CAP). The ADF is supporting 30 livestock and forage-related research projects this year which focus on a variety of topics.

    “We are working with the provinces and territories to deliver vitally important programming through Sustainable CAP,” MacAulay said. “Our shared investment with the Government of Saskatchewan in these Agriculture Development Fund research projects will help create growth and make sure our great sector remains on the cutting edge.”

    “Innovation is the key to staying competitive and allowing Saskatchewan to remain a global leader when it comes to new and best practices in agriculture,” Harrison said. “We continue to support this and help Saskatchewan’s livestock producers to keep doing what they do best through investments of this nature, which enables the kind of world-class scientific work that constantly moves the industry forward.”

    The selection and approval of projects supported by the ADF is based on an annual competitive process to identify research with the potential to help Saskatchewan’s livestock producers and agriculture industry remain innovative, profitable and competitive. This year’s livestock and forage-related projects include a range of topics such as enhancing the capacity to research pathogens and manufacture vaccines and therapeutics to help control infectious diseases, including those that cause pandemics; evaluating the combined impact of prescribed fire and post-fire herbicide applications to control woody plants (snowberry) in rangelands; and investigating how trace-mineral supplementation could help feeder calves respond better to vaccines.

    The Governments of Canada and Saskatchewan work closely with industry partners to leverage funding to support research that aligns with industry priorities. This year’s ADF projects were supported by an additional $216,000 contributed to 10 projects by the following industry partners:

    • Saskatchewan Cattlemen’s Association
    • Saskatchewan Forage Seed Development Commission
    • SaskPork
    • Western Dairy Research Collaboration (BC Dairy, Alberta Milk, SaskMilk, and Dairy Farmers of Manitoba)

    “Investment in research is critical for our industry,” Saskatchewan Cattlemen’s Association Chair Keith Day said. “We appreciate both levels of government recognizing its value and investing in our research priorities, which focused on animal health and forage production this year.”

    The ADF is supported through Sustainable CAP, a five-year, $3.5 billion investment by Canada’s federal, provincial and territorial governments that supports Canada’s agri-food and agri-product sectors. This includes $1 billion in federal programs and activities and a $2.5 billion commitment that is cost-shared 60 per cent federally and 40 per cent provincially/territorially for programs that are designed and delivered by provinces and territories.

    For more information, including a full list of the above projects, please visit:
    https://www.saskatchewan.ca/business/agriculture-natural-resources-and-industry/agribusiness-farmers-and-ranchers/sustainable-canadian-agricultural-partnership/programs-for-research/agriculture-development-fund.

    -30-

    For more information, contact:

    MIL OSI Canada News –

  • MIL-OSI Global: Robert F. Kennedy Jr.’s nomination signals a new era of anti-intellectualism in American politics

    Source: The Conversation – USA – By Dominik Stecuła, Assistant Professor of Communication and Political Science, The Ohio State University

    Donald Trump’s nominee for secretary of the Department of Health and Human Services, Robert Kennedy Jr., on Capitol Hill on Jan. 9, 2025. Jon Cherry/Getty Images

    The many controversial people appointed to the Trump administration, from Elon Musk to Robert F. Kennedy Jr., have at least one thing in common: They dislike and distrust experts.

    While anti-intellectualism and populism are nothing new in American life, there has hardly been an administration as seemingly committed to these worldviews.

    Take President Donald Trump’s decision to nominate Kennedy, a well-known vaccine skeptic, to lead the Department of Health and Human Services. Kennedy, whose Senate confirmation hearing is Jan. 29, 2025, epitomizes the new American political ethos of populism and anti-intellectualism, or the idea that people hold negative feelings toward not just scientific research but those who produce it.

    Anti-intellectual attacks on the scientific community have been increasing, and have become more partisan, in recent years.

    For instance, Trump denigrated scientific experts on the campaign trail and in his first term in office. He called climate science a “hoax” and public health officials in his administration “idiots.”

    Skepticism, false assertions

    This rhetoric filtered into public discussion, as seen in viral social media posts mocking and attacking scientists like Dr. Anthony Fauci, or anti-mask protesters confronting health officials at public meetings and elsewhere.

    Trump and Kennedy have cast doubt on vaccine safety and the medical scientific establishment. As far back as the Republican primary debates in 2016, Trump falsely asserted that childhood vaccines cause autism, in defiance of scientific consensus on the issue.

    Kennedy’s long-term vaccine skepticism has also been well documented, though he himself denies it. More recently, he has been presenting himself as “pro-vaccine safety,” as one Republican senator put it, on the eve of Kennedy’s confirmation hearing.

    A researcher works in the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health.
    National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health

    Kennedy has mirrored Trump’s anti-intellectual rhetoric by referring to government health agency culture as “corrupt” and the agencies themselves as “sock puppets.”

    If confirmed, Kennedy has vowed to turn this anti-intellectual rhetoric into action. He wants to replace over 600 employees in the National Institutes of Health with his own hires. He has also suggested cutting entire departments.

    During one interview, Kennedy said, “In some categories, there are entire departments, like the nutrition department at the FDA, that are – that have to go.”

    Populism across political spectrum

    In lockstep with this anti-intellectual movement is a version of populism that people like RFK Jr. and Trump both espouse.

    Populism is a worldview that pits average citizens against “the elites.” Who the elites are varies depending on the context, but in the contemporary political climate in the U.S., establishment politicians, scientists and organizations like pharmaceutical companies or the Centers for Disease Control and Prevention are frequently portrayed as such.

    For instance, right-wing populists often portray government health agencies as colluding with multinational pharmaceutical companies to impose excessive regulations, mandate medical interventions and restrict personal freedoms.

    Left-wing populists expose how Big Pharma manipulates the health care system, using their immense wealth and political influence to put profits over people, deliberately keeping lifesaving medications overpriced and out of reach – all of which has been said by politicians like Bernie Sanders.

    The goal of a populist is to portray these elites as the enemy of the people and to root out the perceived “corruption” of the elites.

    This worldview doesn’t just appeal to the far right. Historically in the United States, populism has been more of a force on the political left. To this day, it is present on the left through Sanders and similar politicians who rail against wealth inequality and the interests of the “millionaire class.”

    In short, the Trump administration’s populist and anti-intellectual worldview does not map cleanly onto the liberal-conservative ideological divide in the U.S. That is why Kennedy, a lifelong Democrat and nephew of a Democratic president, might become a Cabinet member for a Republican president.

    The cross-ideological appeal of populism and anti-intellectualism also partly explains why praise for Trump’s selection of Kennedy to head the Department of Health and Human Services came from all corners of society. Republican senators Ron Johnson and Josh Hawley lauded the move, as did basketball star Rudy Gobert and Colorado’s Democratic governor, Jared Polis.

    Even former President Barack Obama once considered Kennedy for a Cabinet post in 2008.

    Republican presidential nominee Donald Trump is greeted by Robert F. Kennedy Jr. on stage during a campaign event on Aug. 23, 2024, in Glendale, Ariz.
    Tom Brenner for The Washington Post via Getty Images

    Anger at elites

    Why, then, is disdain for scientific experts appealing to so many Americans?

    Much of the public supports this worldview because of perceived ineffectiveness and moral wrongs made by the elites. Factors such as the opioid crisis encouraged by predatory pharmaceutical companies, public confusion and dissatisfaction with changing health guidance in the early stages of the COVID-19 pandemic, and the frequently prohibitive cost of health care and medicine have given some Americans reason to question their trust in science and medicine.

    Populists have embraced popular and science-backed policies that align with an anti-elite stance. Kennedy, for example, supports decreasing the amount of ultra-processed foods in public school lunches and reducing toxic chemicals in the food supply and natural environment. These stances are backed by scientific evidence about how to improve public health. At the same time, they point to the harmful actions of a perceived corrupt elite – the profit-driven food industry.

    It is, of course, reasonable to want to hold accountable both public officials for their policy decisions and scientists and pharmaceutical companies who engage in unethical behavior. Scientists should by no means be immune from scrutiny.

    Examining, for example, what public health experts got wrong during the COVID-19 pandemic would be tremendously helpful from the standpoint of preparing for future public health crises, but also from the standpoint of rebuilding public trust in science, experts and institutions.

    However, the Trump administration does not appear to be interested in pursuing good faith assessments. And Trump’s victory means he gets to implement his vision and appoint people he wants to carry it out. But words have consequences, and we have seen the impact of anti-vaccine rhetoric during the COVID-19 pandemic, where “red” counties and states had significantly lower vaccine intent and uptake compared with the “blue” counterparts.

    Therefore, despite sounding appealing, Kennedy’s signature slogan, “Make America Healthy Again,” could – in discouraging policies and behaviors that have been proven effective against diseases and their crippling or deadly outcomes – bring about a true public health crisis.

    Dominik Stecuła receives funding from the National Science Foundation.

    Kristin Lunz Trujillo receives funding from the National Science Foundation.

    Matt Motta receives funding from the National Science Foundation.

    – ref. Robert F. Kennedy Jr.’s nomination signals a new era of anti-intellectualism in American politics – https://theconversation.com/robert-f-kennedy-jr-s-nomination-signals-a-new-era-of-anti-intellectualism-in-american-politics-246016

    MIL OSI – Global Reports –

  • MIL-OSI United Kingdom: Chancellor vows to go further and faster to kickstart economic growth

    Source: United Kingdom – Executive Government & Departments

    Chancellor of the Exchequer Rachel Reeves spoke at Siemens Healthineers in Oxfordshire on 29 January 2025.

    Thank you everyone. 

    It’s fantastic to be here at Siemens at this amazing facility.  

    Today, I want to talk about economic growth. 

    Why it matters.  

    How we achieve it.  

    And what we are going to do further and faster to deliver it. 

    Before we came into office… 

    … the Prime Minister and I have said loud and clear:  

    Economic growth is the number one mission of this government.  

    Without growth, we cannot cut hospital waiting lists or put more police on the streets.  

    Without growth, we cannot meet our climate goals… 

    … or give the next generation the opportunities that they need to thrive. 

    But most of all… 

    … without economic growth… 

    … we cannot improve the lives of ordinary working people.  

    Because growth isn’t simply about lines on a graph. 

    It’s about the pounds in people’s pockets. 

    The vibrancy of our high streets. 

    And the thriving businesses that create wealth, jobs and new opportunities for us, for our children, and grandchildren.  

    We will have succeeded in our mission when working people are better off. 

    I know that the cost of living crisis is still very real for many families across Britain.  

    The sky high inflation and interest rates of the past few years have left a deep mark… 

    … with too many people still making sacrifices to pay the bills and to pay their mortgages.   

    But we have begun to turn this around.  

    Everything I see as I travel around the country gives me more belief in Britain. 

    And more optimism about our future. 

    Because we as a country have huge potential.  

    A country of strong communities, with small and local businesses at their heart.  

    We are at the forefront of some of the most exciting developments in the world… 

    … like artificial intelligence and life sciences…  

    … with great companies like DeepMind, AstraZeneca, Rolls Royce… and of course Siemens…  

    … delivering jobs and investment across Britain. 

    We have fundamental strengths – in our history, in our language, and in our legal system – to compete in a global economy.  

    But for too long, that potential has been held back.  

    For too long, we have accepted low expectations and accepted decline. 

    We no longer have to do that.  

    We can do so much better. 

    Low growth is not our destiny.  

    But growth will not come without a fight.  

    Without a government willing to take the right decisions now to change our country’s future for the better. 

    That’s what our Plan for Change is all about. 

    That is what drives me as Chancellor.  

    In my Mais lecture in March last year, I set out my approach to achieving economic growth… 

    … and identified the fundamental barriers to realising our full potential.  

    The productive capacity of the UK economy has become far too weak.  

    Productivity, the driver of living standards…   

    …has grown more slowly here than in countries like Germany and the US.  

    The supply side of our economy has suffered due to chronic underinvestment… 

    … and stifling and unpredictable regulation…  

    … not helped by the shocks we have faced in recent years. 

    [redacted political content]

    The strategy that I have consistently set out… 

    … is to grow the supply-side of our economy… 

    … recognising that first and foremost… 

    … it is businesses, investors and entrepreneurs who drive economic growth… 

    … a government that systematically removes the barriers that they face – one by one and has their back 

    This strategy has three essential elements: 

    First, stability in our politics, our public finances and our economy – the basic condition for secure economic growth. 

    Second, reform – reform which makes it easier for businesses to trade, to raise finance and to build.  

    And third, investment, the lifeblood of economic growth. 

    Let me explain each of those in turn.  

    Stability – the first line of our manifesto was a promise to bring stability to the public finances.  

    It is the rock upon which everything else is built. 

    And it is the essential foundation of our Plan for Change.  

    Because economic stability is the precondition for economic growth. 

    That’s why the first piece of legislation that we passed as a government was the Budget Responsibility Act… 

    … so never again will we see our independent forecaster sidelined.

    [redacted political content]

    At my first Budget in October… 

    … it was my duty as Chancellor… 

    … to fix the foundations of our economy, and repair the public finances that we inherited. 

    To restore stability and create the conditions for growth and investment.  

    I set out new fiscal rules which are non-negotiable, and will always be met. 

    We began to rebuild our NHS and our schools – the start of a programme of public service reform.  

    I capped the rate of corporation tax – and I extended our generous capital allowances for the duration of this parliament – as the CBI and the BCC have long called for.  

    And I protected working people after a cost of living crisis… 

    … by freezing fuel duty… 

    … and with no increases in their National Insurance, Income Tax or VAT. 

    But taking the right decisions and the responsible decisions does not always mean taking the easy decisions. 

    The increase in Employers’ National Insurance contributions has consequences on business and beyond.   

    I said that up front in my Budget speech. 

    I accept that there are costs to responsibility. 

    But the costs of irresponsibility would have been far higher. 

    Those who oppose my Budget know that too. 

    That is why, since October, I have seen no alternative put forward [redacted political content].

    No alternatives to deal with the challenges we face.  

    No alternatives to restoring economic stability… 

    … and therefore no plan for driving economic growth. 

    Alongside stability, we need to drive forward the reform which makes investment more likely… 

    … by removing the constraints on the supply side of our economy… 

    … making it easier for businesses to trade… 

    … to raise finance… 

    … and to build.  

    Let me first address our approach to trade.  

    We stand at a moment of global change.  

    In that context, we should be guided by one clear principle above all.  

    To act in the national interest… 

    … for our economy… 

    … for our businesses… 

    … and for the British people. 

    That means building on our special relationship with the United States under President Trump. 

    The Prime Minister discussed the vital importance of growth with the President last weekend…  

    … and I look forward to working with the new Treasury Secretary, Scott Bessent… 

    … to deepen our economic relationship in the months and the years ahead. 

    Acting in our national interest also means resetting our relationship with the EU – our nearest and our largest trading partner – to drive growth and support business.  

    We are pragmatic about the challenges that we have inherited from the last government’s failed Brexit deal.  

    But we are also ambitious in our goals.  

    [redacted political content]

    … we will prioritise proposals that are consistent with our manifesto commitments… 

    … and which contribute to British growth and British prosperity… 

    … because that is what the national interest demands.  

    Our approach to trade also means building stronger relationships with fast-growing economies all around the world. 

    That is why I led a delegation to China for the first Economic and Financial Dialogue since 2019… 

    … alongside world-leading financial service businesses, including HSBC, Standard Chartered and Schroders…  

    … unlocking £600 million of tangible benefits for the UK economy. 

    And I am pleased to confirm that the Business and Trade Secretary will shortly visit India … 

    … to restart talks on the free trade agreement and bilateral investment treaty [redacted political content].  

    Our businesses can only realise these opportunities if they can recruit the skilled staff that they need. 

    So we are reforming our employment system to create a national jobs and careers service. 

    We have created Skills England to meet the skills of the next decade in sectors like construction and engineering.  

    And we will deliver fundamental reform of our welfare system.  

    That includes looking at areas that have been ducked for too long… 

    … like the rising cost of health and disability benefits… 

    … and the Secretary of State for Work and Pensions will set out our plans to address this ahead of the Spring Statement.  

    Next, the Immigration White Paper, that will bring forward concrete proposals to bring the overall levels of net migration down. 

    But we know that the UK is in an international competition for talent in vital growth sectors.    

    That is why last week, I set out plans for attracting global talent. 

    We will look at the visa routes for very highly skilled people…  

    … so the best people in the world choose the UK to live, work and create wealth… 

    … bringing jobs and investment to Britain. 

    To help businesses access the finance and support they need to grow…  

    … we have delivered significant reforms to provide greater flexibility for firms and founders to raise finance on UK capital markets, by rewriting the UK’s listing rules.  

    In my Mansion House speech, I announced a series of reforms to our pensions system…  

    … including the creation of larger, consolidated funds… 

    … which have much greater capacity to invest in high growth British companies at the scale that we need them to.  

    The consultation on these reforms is already complete and the final report will be published in the Spring. 

    Yesterday we confirmed that we have plans to go further, whilst always protecting the important role that pension funds play in the gilt market. 

    We will introduce new flexibilities for well-funded Defined Benefit schemes… 

    … to release surplus funds where it is safe to do so… 

    … generating even more investment into some of our fastest growing industries. 

    I know too that businesses are held back by a complex and unpredictable regulatory system… 

    … and that is a drag on investment and innovation. 

    We have already provided new growth-focused remits to our financial services regulators… 

    … we have announced a new interim Chair of the Competition and Markets Authority…  

    … and we have established the Regulatory Innovation Office, with an initial focus on synthetic biology, space, AI, and connected and autonomous vehicles.  

    But we need to go further and we need to go faster.  

    So earlier this month, I met the Heads of some of our largest regulators. 

    They have already provided a range of options to drive growth in their sectors… 

    … and proposals for how they can be more agile and responsive to businesses… 

    … and we will publish that final action plan in March to make regulation work much better for our economy. 

    To get Britain building again… 

    … we have delivered the most significant reforms to our planning system in a generation.  

    I have been genuinely shocked about how slow our planning system is. 

    By how long it takes to get things done.  

    Take the decision to build a solar farm in Cambridgeshire – a decision the Energy Secretary took only a few weeks into the job in July… 

    [redacted political content]

    The Deputy Prime Minister has already driven significant progress across government in addressing these issues.   

    My colleagues have determined 13 major planning decisions in just six months… 

    … including for airports, data centres and major housing developments.   

    We have significantly raised housing targets across our country and made them mandatory, so that we can build one-and-a-half million homes in this parliament.  

    We have reformed decades-old “green belt” policies, making it easier to build on the “grey belt” land around our major cities. 

    And we have opened up our planning system to build new infrastructure – like onshore wind farms or data centres driving the AI revolution. 

    Having listened closely to calls from business groups like the Institute of Directors… 

    … and businesses across our economy about the need to speed up infrastructure delivery… 

    … including Mace, Skanska and Arup who are here today… 

    … and members of our British Infrastructure Taskforce like Lloyds, Blackrock and Phoenix… 

    … we have now set out plans to go even further. 

    Last week we confirmed our priorities for the Planning and Infrastructure Bill … 

    … to rapidly streamline the process for determining applications… 

    … to make the consultation process far less burdensome… 

    … and to fundamentally reform our approach to environmental regulation. 

    The problems in our economy… 

    … the lack of bold reform that we have seen over decades… 

    … can be summed up by a £100 million bat tunnel built for HS2… 

    … the type of decision that has made delivering major infrastructure in our country far too expensive and far too slow. 

    So we are reducing the environmental requirements placed on developers when they pay into the nature restoration fund that we have created… 

    …so they can focus on getting things built, and stop worrying about bats and newts.  

    And to build our new infrastructure like nuclear power plants, trainlines and windfarms more quickly… 

    … we are changing the rules to stop blockers getting in the way of development… 

    … through excessive use of Judicial Review. 

    This Bill, the Planning and Infrastructure Bill, is a priority for this government. 

    It will be introduced in the Spring… 

    … and we will work tirelessly in parliament to ensure its smooth, and speedy and rapid delivery.  

    By providing a foundation of economic stability… 

    … and by delivering the reforms needed to make it easier for businesses to succeed and grow… 

    … we will create the right conditions to increase investment in our economy – the final key element of our strategy. 

    Investment and innovation go hand in hand.  

    I want to see the sounds and the sights of the future arriving.    

    Delivered by amazing businesses like Wayve and Oxford Nanopore. 

    They are the future. 

    And Britain should be the best place in the world to be an entrepreneur. 

    That is why we protected funding for research and development… 

    … and it is why one of the first decisions I made as Chancellor… 

    … was to extend the Enterprise Investment Scheme and the Venture Capital Trust schemes for a further 10 years… 

    … to get more investment into new companies, driving their innovation and growth.  

    I am determined to make Britain the best place in the world to invest.  

    That was my message in Davos last week.  

    That ambition demands action. 

    The International Investment Summit that we hosted in October delivered £63 billion of investment right across our country… 

    … from Iberdrola doubling its investment in clean energy in places like Suffolk… 

    … Blackstone investing £10 billion in a data centre in Northumberland… 

    … and Eren Holdings investing £1 billion in advanced manufacturing in North Wales.  

    While the lifeblood of growth is business investment, a strategic state has a crucial role to play. 

    That is why we established the National Wealth Fund… 

    … to create that partnership between business, private investors and government to invest in the industries of the future…  

    … like clean energy. 

    Today I can announce two further investments by the National Wealth Fund. 

    First, a £65 million investment for Connected Kerb, to expand their electric vehicle charging network across the UK. 

    And second, a £28 million equity investment in Cornish Metals… 

    … providing the raw materials to be used in solar panels, wind turbines and electric vehicles… 

    … supporting growth and jobs in the South-West of England.  

    There is no trade-off between economic growth and net zero. 

    Quite the opposite. 

    Net zero is the industrial opportunity of the 21st century, and Britain must lead the way. 

    That is why we will publish a refreshed Carbon Budget Delivery Plan later this year, which alongside the Spending Review, will set out our plans to deliver Carbon Budget 6. 

    Today, I can also announce that we are removing barriers to deliver 16 gigawatts of offshore wind…   

    … by designating new Marine Protected Areas to enable the development of this technology in areas like East Anglia and Yorkshire… 

    … crowding in up to £30 billion of investment in homegrown clean power. 

    And there’s more. 

    Our industrial and manufacturing base, brilliantly represented by Make UK, have been banging their heads against the wall for years at the lack of a proper industrial strategy from government. 

    That is why we have launched our modern industrial strategy… 

    … to drive investment into the industries that will define our success in the years ahead. 

    We have already provided funding to unlock investment in sectors like aerospace, automotives and life sciences… 

    … and we have set out reforms to boost financial services, the AI sector and creative industries. 

    We are not wasting any time, and we will move forward with the next stages of the Industrial Strategy ahead of its publication in the Spring.  

    We will work with the private sector to deliver the infrastructure that our country desperately needs.  

    This includes the Lower Thames Crossing, which will improve connectivity at Port of Tilbury and Dover, London Gateway and Medway… 

    … alleviating severe congestion… 

    … as goods destined for export come from the North, and the Midlands and across the country to markets overseas.   

    To drive growth and deliver value for money for taxpayers, we are exploring options to privately finance this important project.  

    And we have changed course on public investment, too… 

    … with a new Investment Rule to ensure that we don’t just count the costs of investment – we count the benefits too.    

    We are now investing 2.6% of GDP on average over the next five years, compared to 1.9% planned by the previous government..  

    … delivering an additional £100 billion of growth-enhancing capital spending… 

    … which catalyses private sector investment… 

    … in more housing… 

    … better transport links… 

    … and clean energy.  

    These are significant steps in just six months… 

    … and we are seeing some encouraging signs in the British economy. 

    The IMF have upgraded our growth prospects for 2025… 

    … the only G7 country outside the US to see this happen.  

    This gives us the fastest growth of any major European economy this year.  

    And a global survey of CEOs by PWC, has shown Britain is now the second most attractive country in the world for businesses looking to invest.  

    The first time the UK has been in that position for 28 years.  

    This is all welcome news.  

    But there is still more that we can and will do.  

    I am not satisfied with the position we are in. 

    While we have huge amounts of potential, the structural problems in our economy run deep. 

    And the low growth of the last 14 years cannot just be turned around overnight. 

    This has to be our focus for the duration of the parliament.  

    Because the situation demands us to do more. 

    And today I will go further and faster in kickstarting economic growth. 

    Our mission to grow our economy is about raising living standards in every single part of the United Kingdom.  

    Manchester is home to the UK’s fastest growing tech sector.  

    Leeds is one of the largest financial services centres outside of London.  

    These great northern cities have so much potential and promise… 

    …which our brilliant metro mayors, Andy Burnham and Tracy Brabin, are working hard to realise…  

    … just like our other metro mayors are doing to deliver new opportunities in their areas.  

    And there is so much more that government can do to support our city regions.    

    To achieve this requires greater focus on two key areas: infrastructure and investment.  

    If we can improve connectivity between towns and cities across the North of England, we can unlock their true growth potential… 

    … by making it easier for people to live, travel and work across the area.  

    At the Budget, I set out funding for the Transpennine Route Upgrade… 

    … a multi-billion-pound programme of improvements that will connect towns and cities from Manchester to York via Stalybridge, Leeds and Huddersfield. 

    We are delivering railway schemes to improve journeys for people across the North… 

    … including upgrades at Bradford Forster Square and by electrifying the Wigan-Bolton line. 

    We have committed to supporting the delivery of a new mass transit system in West Yorkshire.  

    And in Spring, we will publish the Spending Review and a 10-Year Infrastructure Strategy… 

    … which will set out further detail of our plans for infrastructure right across the UK. 

    New transport infrastructure can also act as a catalyst for new housing. 

    We have already seen the benefits that unlocking untapped land around stations can deliver in places like Stockport… 

    … where joint work spearheaded by Andy Burnham and council leaders has delivered new housing and wider commercial opportunities. 

    We will introduce a new approach to planning decisions on land around stations, changing the default answer to yes. 

    We are working with the devolved governments to ensure the benefits of growth can be felt across Scotland, Wales and Northern Ireland… 

    … including by partnering with them on the Industrial Strategy to support their considerable sectoral strengths. 

    And in December, I met with Metro Mayors from across England.  

    They told me that more opportunities for investment are vital if their local economies are to grow in the years ahead. 

    We are listening closely to them. 

    As the Metro Mayor of Liverpool, Steve Rotherham, has called for… 

    … we will review the Green Book and how it is being used to provide objective, transparent advice on public investment across the country, including outside London and the Southeast.  

    This means that investment in all regions is given a fair hearing by the Treasury that I lead. 

    The Office for Investment is going to be working hand in hand with local areas… 

    … to develop a commercially attractive pipeline of investment opportunities for a global audience… 

    … starting with the Liverpool City Region and the North East Combined Authority, led by Kim McGuinness. 

    The National Wealth Fund is establishing strategic partnerships to provide deeper, more focused support for city regions, starting in Glasgow, West Yorkshire, the West Midlands, and Greater Manchester. 

    We are supporting key investment opportunities across the UK. 

    The government is backing Andy Burnham’s plans for the redevelopment of Old Trafford, which promises to create new housing and commercial development around a new stadium… 

    … to drive regeneration and growth in the area. 

    We are moving forward with the Wrexham and Flintshire Investment Zone… 

    … focusing on the area’s strengths in advanced manufacturing… 

    … backed by major businesses like Airbus and JCB… 

    … to leverage £1 billion of private investment in the next ten years… 

    … creating up to 6,000 jobs. 

    [redacted political content]

    So I can announce today that we will work with Doncaster Council and the Mayor of South Yorkshire, Oliver Coppard… 

    … to support their efforts to recreate South Yorkshire Airport City as a thriving regional airport.  

    And finally, I am pleased to announce a partnership between Prologis and Manchester Airport Group in the East Midlands, where the Metro Mayor Claire Ward is doing an excellent job growing the local economy there. 

    Prologis and MAG will work together to build a new advanced manufacturing and logistics park at East Midlands Airport … 

    … unlocking up to £1 billion of investment and 2,000 jobs at the site… 

    … a major investment from a global business into our country… 

    … representing a huge vote of confidence in the East Midlands and in the UK. 

    This is just the start of our work to get more investment into every nation and region of Britain. 

    Next, I want to set out further detail for plans for the area we are in today.  

    Oxford and Cambridge offer huge potential for our nation’s growth prospects. 

    Only 66 miles apart… 

    … these cities are home to two of the best universities in the world… 

    … and the area is a hub for globally renowned science and technology firms. 

    This area has the potential to be Europe’s Silicon Valley.  

    To make that a reality, we need a systematic approach to attract businesses to come here and to grow here. 

    At the moment, it takes over two and a half hours to travel between Oxford and Cambridge by train.  

    There is no way to commute directly by rail from places like Bedford and Milton Keynes to Cambridge. 

    And there is a lack of affordable housing right across the region.  

    In other words, the demand is there… 

    … but there are far too many supply side constraints on economic growth here.  

    We are going to fix that.  

    The Ox Cam arc was initially launched in 2003 – over 20 years ago.  

    [redacted political content]

    We are not prepared to miss out on the opportunities here any longer.  

    So working with the Deputy Prime Minister… 

    … who is already driving forward vital work in the region…  

    … we are going further and faster to unlock the potential of the Oxford-Cambridge Growth Corridor.   

    First, we are funding the transport links needed to make the Oxford Cambridge growth corridor a success… 

    … including East-West Rail, with new services between Oxford and Milton Keynes starting this year… 

    … and road upgrades to reduce journey times between Milton Keynes and Cambridge. 

    East West Rail will also support vibrant new and expanded communities along the route. 

    We have already received proposals for New Towns along the new railway… 

    … with 18 submissions for sizeable new developments. 

    At Tempsford – the nexus of the East Coast Mainline, the A1 and East West Rail… 

    …we will move quicker to deliver a mainline station, meaning journey times to London of under an hour…  

    … and to Cambridge in under 30 minutes when East West Rail is operational. 

     Second, we are ensuring that the area has the right infrastructure and public services in place to support the growth corridor as it expands. 

    A new Cambridge Cancer Research Hospital is being prioritised for investment as part of wave 1 of the New Hospital Programme.  

    Water infrastructure has also been a major hindrance to development. 

    So we have now agreed water resources management plans, unlocking £7.9 billion of investment in the next 5 years…  

    …including plans for the new Fens Reservoir serving Cambridge and the South East Strategic Reservoir near Oxford.  

    And I can confirm today that the Environment Agency have now lifted their objections to new development in Cambridge, following this government’s intervention to address water scarcity… 

    … which means 4,500 additional homes, new schools, and new office, retail and laboratory space can be built.  

    Third, I am delighted that Cambridge University have come forward with plans for a new flagship innovation hub at the centre of Cambridge… 

    … to attract global investment and foster a community that catalyses innovation, as other cities around the world like Boston and Paris have done.  

    Just yesterday, Moderna completed the build for their new vaccine production and R&D site in Harwell, right here in Oxfordshire, alongside a commitment to invest a further £1 billion in the UK.  

    And we are creating a new AI Growth Zone in Culham to speed up planning approvals for the rapid build-out of data centres.  

    And finally, to take this project forward at real pace… 

    … and catalyse private sector investment into the region… 

    … I am pleased to announce that the Deputy Prime Minister and I have asked Lord Patrick Vallance to be the champion for the Oxford Cambridge Growth Corridor.  

    Lord Vallance has extensive experience across the sciences, academia, and government. 

    He will work with local leaders and with the Housing and Planning Minister to deliver this exciting project… 

    … including with Peter Freeman, who is already doing excellent work in Cambridge… 

    … and a new Growth Commission for Oxford, which will help to accelerate growth in the city and its surrounding area.   

    This is the government’s modern Industrial Strategy in action. 

    With central government, local leaders and business working together… 

    … the Oxford and Cambridge Growth Corridor could add up to £78 billion to the UK economy by 2035 … 

    … driving investment, innovation and growth. 

    Finally, I come to the decision that perhaps more than any other… 

    … has been delayed… 

    … has been avoided… 

    … has been ducked. 

    The question of whether to give Heathrow … 

    … our only hub airport… 

    … a third runway… 

    … has run on for decades. 

    The last full length runway in Britain was built in the 1940s. 

    No progress in eighty years.  

    Why is this so damaging?  

    It’s because Heathrow is at the heart of the UK’s openness as a country.   

    It connects us to emerging markets all over the world, opening up new opportunities for growth. 

    Around three-quarters of all long-haul flights in the UK go from Heathrow. 

    Over 60% of UK air freight comes through Heathrow. 

    And about 15 million business travellers used Heathrow in 2023. 

    But for decades, its growth has been constrained.  

    Successive studies have shown that this really matters for our economy. 

    According to the most recent study from Frontier Economics, a third runway could increase potential GDP by 0.43% by 2050. 

    Over half – 60% of that boost, would go to areas outside London and the South-East. 

    … increasing trade opportunities for products like Scotch whiskey and Scottish salmon – already two of the biggest British exports out of Heathrow.  

    And a third runway could create over 100,000 jobs. 

    For international investors, persistent delays have cast doubt about our seriousness towards improving our economic prospects. 

    Business groups, like the CBI, the Federation of Small Businesses and the Chambers of Commerce right across the UK… 

    …as well trade unions like GMB and Unite are clear… 

    … a third runway is badly needed. 

    In 2018, the previous government steered its Airports National Policy Statement through parliament.  

    But no action was taken. 

    It simply sat on the shelf. 

    We are taking a totally different approach to airport expansion.  

    This Government has already given its support to expansion at City Airport and at Stansted.  

    And there are two live decisions on Luton and Gatwick which will be made by the Transport Secretary shortly.  

    But as our only hub airport, Heathrow is in a unique position – and we cannot duck the decision any longer.   

    I have always been clear that a third runway at Heathrow would unlock further growth… 

    … boost investment… 

    … increase exports… 

    … and make the UK more open and more connected.   

    And now, the case is stronger than ever… 

    … because our reforms to the economy… 

    … like speeding up the planning system… 

    … and our plans for modernised UK airspace…  

    … mean the delivery of this project is set up for success.  

    So I can confirm today that this Government supports a third runway at Heathrow… 

    … and is inviting proposals to be brought forward by the summer.  

    We will then take forward a full assessment through the Airport National Policy Statement. 

    That will ensure that the project is value for money – and our clear expectation is that any associated surface transport costs will be financed through private funding. 

    And it will ensure that a third runway is delivered in line with our legal, environmental and climate obligations.  

    Heathrow themselves are clear that their proposal for expansion will meet strict rules on noise, air quality and carbon emissions. 

    And we are already making great strides in transitioning to cleaner and greener aviation.  

    Sustainable Aviation Fuel reduces CO2 emissions compared to fossil fuel by around 70%. 

    At the start of this month, the Sustainable Aviation Fuel mandate became law.  

    And today I can announce that we are investing £63 million into the Advanced Fuels Fund over the next year… 

    … and we have today set out the details of how we will deliver a Revenue Certainty Mechanism to encourage investment into this growing industry. 

    These measures will encourage more investors to back production in the UK, bringing good, high-skilled jobs to areas like Teesside… 

    … demonstrating that investment in the right technology can help us deliver both our growth and our clean energy missions. 

    Now is the moment to grasp the opportunity in front of us. 

    By backing a third runway at Heathrow, we can make Britain the world’s best connected place to do business. 

    That is what it takes to make bold decisions in the national interest. 

    That is what I mean by going further and faster to kickstart economic growth. 

    The work of change has begun.  

    We have already made great progress.  

    But I am not satisfied.  

    And I know that there is more to be done.  

    We must go further and faster if we are to build a brighter future.  

    The prize on offer is immense.  

    The next generation with more opportunities than the last. 

    An engineer in Teesside, working in some of the most exciting industries of the future – from carbon capture to sustainable aviation fuel. 

    A scientist in Milton Keynes or Bedford, working in our life sciences industry to solve some of the most important medical challenges in the world.  

    A small business owner in Scotland, knowing that they can expand and export to new markets right across the globe.   

    Wealth created, and wealth shared, in every part of Britain.    

    This is a Government on the side of working people. 

    Taking the right decisions to secure their future, to secure our future. 

    Stepping up to the challenges we face. 

    Ending the era of low expectations. 

    Putting Britain on a different path. 

    Delivering for the British people. 

    And I am determined, this Government is determined, to do just that.  

    Thank you.

    Updates to this page

    Published 29 January 2025

    MIL OSI United Kingdom –

  • MIL-OSI Africa: WHO in Africa: three ways the continent stands to lose from Trump’s decision to pull out

    Source: The Conversation – Africa – By Lawrence O. Gostin, University Professor; Founding Linda D. & Timothy J. O’Neill Professor of Global Health Law, Georgetown University

    President Donald Trump’s decision to withdraw the US from the World Health Organization (WHO) will be keenly felt across the globe, with profound implications for health in Africa.

    In the executive order putting the withdrawal process in place, Trump also paused the transfer of US funds, support and resources to the WHO.

    Trump’s executive order is his second attempt to pull the US out of the agency. He has also complained that the US financial contribution to the international organisation is “onerous”.

    The biggest impacts will come from the loss of US funding. The US is by far the WHO’s largest state donor, contributing approximately 18% of the agency’s total funding.

    The WHO’s funding is split into two tranches.

    There are assessed contributions: countries’ membership fees, to which all WHO members agree and over which the WHO has full control. The US accounts for 22%, or US$264 million of these, for the current 2024/25 budget. The US is yet to pay the WHO its assessed contributions for 2024 and 2025. Withdrawing from the organisation without paying these fees would violate US law and must be challenged in the US courts.

    Then there are voluntary contributions: donations by member countries, foundations and other sources, usually earmarked to that donor’s priorities. The US contributes 16%, or US$442 million, of all voluntary contributions.

    In the case of the US, these priorities include HIV/AIDS, polio eradication and health emergencies.

    As experts in global health law, we are deeply concerned about the impacts of this order, which will be far reaching.

    The US withdrawal from the WHO threatens core health programmes in Africa. It will weaken the ability of African countries to respond to health emergencies, and could lead to increases in death and illness on the continent.

    It will also have broader implications for leadership and governance in global health.

    Impact on core programmes

    Trump’s decision to withdraw comes at a time when the WHO’s health priorities in Africa were already underfunded. Eight of 12 areas were funded less than 50% earlier this year.

    Twenty-seven percent of all US funding through the WHO for the African region goes to polio eradication, 20% supports improved access to quality essential health services, and much of the balance goes to pandemic preparedness and response.

    The WHO/US partnership has long supported the HIV/AIDS response in Africa, but the redirection and reduction in funds could reduce the availability of prevention, testing and treatment programmes across the continent. This threatens progress to end AIDS by 2030.

    The funding gap will also have an impact on programmes designed to increase access to quality essential health services, including the prevention and treatment of tuberculosis and malaria, and child and maternal health services.

    If the WHO is forced to cut back on these services due to a lack of financing, it could lead to increases in mortality and morbidity in Africa.

    European countries filled the financing gap in 2020 when Trump last withheld US funding from the WHO. But it is unlikely that they will be able to do so again, as countries across Europe are facing their own geopolitical and financial challenges.

    The WHO’s budget was already thinly spread, and its mandate keeps growing.

    Through its new investment round, the WHO raised US$1.7 billion in pledges, and is expecting another US$2.1 billion through partnerships and other agreements. Yet even before the US president’s executive order, this left a funding gap of approximately US$3.3 billion (or 47%) for the WHO’s 2025-2028 strategy.

    If the gap left by the loss of US funding cannot be filled from other sources, it will fall to African nations to fund health programmes and services that are cut, placing a greater strain on governments reckoning with limited fiscal space.

    Weakened response to health emergencies

    Trump’s decision comes at a pivotal moment for health in Africa, which is experiencing major outbreaks.

    The US has been a key actor supporting WHO-led emergency responses to outbreaks.

    Last year, the US partnered with the WHO and Rwanda to rapidly bring a Marburg outbreak under control. The Marburg virus continues to threaten the continent. Tanzania has just confirmed an outbreak.

    Earlier in August 2024, the WHO and Africa Centres for Disease Control each declared mpox on the continent to be a public health emergency.

    The Biden administration delivered 60,000 vaccines, pledged 1 million more, and contributed over US$22 million to support capacity building and vaccination.

    But now US health officials have been instructed to immediately stop working with the WHO, preventing US teams in Africa from responding to Marburg virus and mpox.

    Even before these outbreaks, the US supported WHO-led emergency responses to COVID-19, Ebola and HIV/AIDS. The US withdrawal could lead to increased transmission, sickness and death in vulnerable regions.

    Similarly, strong partnership between the WHO and the US has helped build health system capacities in Africa for public health emergencies.

    US experts have supported nearly half of all WHO joint external evaluation missions to assess countries’ pandemic preparedness and response capacities under the International Health Regulations. This is a binding WHO agreement to help countries prepare for, detect and initially respond to health emergencies globally.

    The US withdrawal from the WHO risks eroding these efforts, though it may also accelerate a regionalisation of health security already underway in Africa, led by the African Union through the Africa CDC.

    Restructuring of governance

    The US was instrumental in establishing the WHO and shaping WHO norms and standards, in particular driving amendments to the International Health Regulations adopted in June 2024. This included improved obligations to facilitate the rapid sharing of information between the WHO and countries.

    The US has also been a key figure in ongoing negotiations for a new international treaty, a Pandemic Agreement. This would create new rights and obligations to prevent, prepare for and respond to pandemics with elements that go beyond the International Health Regulations. These include obligations on the equitable sharing of vaccines.

    Trump’s executive order would prevent these instruments from being implemented or enforced in the US.

    This would only entrench inequitable dynamics when the next global health emergency breaks out, given the concentration of global pharmaceutical companies in the US.

    The order also pulls the US out of the Pandemic Agreement negotiations. This will inevitably create new diplomatic dynamics. Optimistically, this could provide enhanced opportunities for African nations to strengthen their position on equity.

    The US departure from the WHO will create a leadership vacuum, ushering in a restructuring of power and alliances for global health.

    This vacuum could cede influence to US adversaries, opening the door to even greater Chinese influence on the African continent.

    But it also presents opportunities for greater African leadership in global health, which could strengthen African self-reliance.

    Trump has directed the US to find “credible and transparent” partners to assume the activities the WHO would have performed. And yet there is no substitute for the WHO, with its worldwide reach and stature.

    For more than 75 years, the WHO has been, and remains, the only global health organisation with the membership, authority, expertise and credibility to protect and promote health for the world’s population.

    For this reason, the African Union, among scores of other bodies and leaders, has already urged Trump to reconsider.

    It is now time for the global community to stand up for the WHO and ensure its vital health work in Africa and beyond can thrive.

    – WHO in Africa: three ways the continent stands to lose from Trump’s decision to pull out
    – https://theconversation.com/who-in-africa-three-ways-the-continent-stands-to-lose-from-trumps-decision-to-pull-out-248237

    MIL OSI Africa –

  • MIL-OSI Russia: What services of the flagship My Documents in the South-East Administrative District are most in demand

    Translartion. Region: Russians Fedetion –

    Source: Moscow Government – Government of Moscow –

    Over the four years of operation, city residents have contacted the flagship office of “My Documents” of the South-Eastern Administrative District more than a million times. It opened in January 2021 on the first floor of the shopping and entertainment center “Gorod” at the address: Ryazansky Prospekt, Building 2, Building 3 and became the fifth flagship in Moscow.

    During this time, the most popular service was the registration of vehicles (TS) and trailers to them – more than 110 thousand requests were recorded. The second most popular service is cadastral registration and (or) registration of rights to real estate objects, more than 70 thousand applications were received for it. The third place in the rating was taken by the service of registration of citizens of the Russian Federation – over 60 thousand requests.

    The flagship offices of My Documents offer unique services that are not available in district centers, such as out-of-court bankruptcy. Young Muscovites can receive their first passport in a ceremonial setting, and Moscow entrepreneurs can use the services of the state budgetary institution Small Business of Moscow, as well as register a legal entity, a peasant (farming) enterprise, and the status of an individual entrepreneur. City residents also have access to vehicle registration services, making changes to registration data, or deregistering a vehicle. This can be done conveniently by prior appointment on the portal Mos.ru or Internet portal of public services.

    At the flagship of the South-Eastern Administrative District, Muscovites can apply for a foreign passport for children under 14 years of age, submit a birth certificate or marriage registration certificate, extracts from the register of legal entities and other documents for legalization, and also enter information about foreign certificates of registration of civil status acts into the Unified State Register of Civil Registry Offices within 24 hours.

    In addition, residents of the capital are provided with two of the most popular services of the guardianship service, related to the issuance of permission for transactions with property and the management of money in the accounts of minors, incapacitated or partially incapacitated citizens.

    On the territory of the flagship office of the South-East Administrative District, newlyweds can register their marriage in a separate hall equipped with a bright photo zone.

    Muscovites are also offered additional services, such as booking a tour in the “My Travels” zone, visiting the “My Photo” photo studio, or visiting the “Moscow – Caring for History” exhibition. The current exhibition is dedicated to the dynasties of Moscow confectioners. In addition, the flagship has a “My Notary” legal bureau, which has become the most popular additional service. Over four years, residents have contacted this bureau more than 40 thousand times.

    The flagship centers are equipped with everything necessary for the convenience and comfort of visitors and are decorated in a modern design. There are spacious waiting areas with soft sofas, USB ports for charging phones and portable lamps, a large children’s area with interactive games and modern cartoons, a mother and child room. You can also charge your mobile device using a portable power bank. All My Documents flagship offices host exhibitions about outstanding cultural figures. The current exhibition is dedicated to Arkady Gaidar.

    The flagship office of “My Documents” in the South-East Administrative District is open daily from 10:00 to 22:00.

    Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.

    Please Note; This Information is Raw Content Directly from the Information Source. It is access to What the Source Is Stating and Does Not Reflect

    https: //vv.mos.ru/nevs/ite/149366073/

    MIL OSI Russia News –

  • MIL-OSI USA: Senator Marshall Releases Statement on President Trump’s Executive Order Protecting Children from Chemical and Surgical Mutilation

    US Senate News:

    Source: United States Senator for Kansas Roger Marshall

    WASHINGTON, D.C. – U.S. Senator Roger Marshall, M.D. released the following statement in response to President Trump’s Executive Order to protect minors from chemical and surgical mutilation procedures and put biology over ideology. 
    Last Congress, Senator Marshall introduced the Safeguarding the Overall Protection of Minors Act to protect America’s children from irreversible physical and emotional harm caused by transgender procedures pushed by the radical Left. 
    “Under President Trump’s leadership, common sense and dignity have returned to the White House. This is another promise made, promise kept by the President and his unwavering commitment to protecting our children from transgender activists in what can only be described as child abuse. President Trump’s Executive Order rightfully prohibits the castration, mutilation, and use of dangerous irreversible therapy treatments on children,” Senator Marshall said.
    Specifically, the Executive Order will: 
    Order agencies to use every available means to cut off federal financial participation in institutions that provide chemical and surgical mutilation of children.
    Taxpayers will no longer fund the chemical and surgical mutilation of children through federal employees’ insurance plans.
    DOJ is ordered to prioritize investigations of those who would subject young women to these barbaric acts under the federal government’s existing statutes which prohibit female genital mutilation and to investigate consumer deception and fraud. 
    It sets in motion Congressional action to empower detransitioners to receive justice against those who so callously led them down this path.
    Background: 
    In December, Senator Marshall introduced landmark legislation, the Safeguarding the Overall Protection of Minors Act which would protect America’s children from the medical dangers of the radical Left’s transgender agenda. 
    The Safeguarding the Overall Protection of Minors Act is a major pillar in Senator Marshall’s fight against the transgender industrial complex that is preying on America’s children. Along with this legislation, Senator Marshall also recently led the Defining Male and Female Act to ensure the legal definition of sex is based on facts, not feelings, which would protect exclusive spaces for women like bathrooms and locker rooms. 
    In November 2024, Senator Marshall brought together a coalition to sound the alarm on the extreme gender ideology war being waged against America’s children and to talk about solutions, including the Safeguarding the Overall Protection of Minors Act. You may click HERE to watch the event hosted by Senator Marshall. 

    MIL OSI USA News –

  • MIL-OSI USA: Senator Marshall on Newsmax: RFK Jr. Will Make America Healthy Again

    US Senate News:

    Source: United States Senator for Kansas Roger Marshall

    Washington, D.C. – U.S. Senator Roger Marshall, M.D. joined Newsmax’s American Agenda to discuss President Trump’s nominee for Health and Human Services (HHS) Secretary, Robert F. Kennedy, Jr., ahead of his confirmation hearings this week. As a member of the Senate Finance and HELP Committees, Senator Marshall will participate in both of RFK Jr.’s confirmation hearings. 
    Senator Marshall is the founder and chairman of the Make America Healthy Again (MAHA) Caucus and has been outspoken in his support for RFK, Jr., who will ensure medical transparency so that Americans can make the best decisions for their health.
    Additionally, Senator Marshall discussed Tulsi Gabbard, President Trump’s nominee for Director of National Intelligence (DNI), and reaffirmed his support for her.
    [embedded content]
    You may click HERE or on the image above to watch Senator Marshall’s full interview.
    Highlights from Senator Marshall’s interview include: 
    On Senator Marshall’s and Mr. Kennedy’s goal to make America healthy again:
    “What Bobby and I share is both a passion to make America healthy again. 60% of Americans have a chronic disease right now, and we want to address that.”
    On Mr. Kennedy’s stance on vaccine transparency and increasing access to medical information for America’s families: 
    “What we both agree upon is the sanctity of the patient and the physician relationship – that my daughter deserves to know everything there is about these vaccines, the pros and cons, the good and the bad with them.”
    “I’ll let Bobby speak for himself. He’ll get asked this 10 times tomorrow, but what he’s going to say is he wants that family, that mom and dad to be armed with all the information. It needs to be nonbiased information. They need to understand the pros and the cons, risk and benefits.”
    On President Trump’s nominee for Director of National Intelligence, Tulsi Gabbard: 
    “I think the thing about Tulsi is she’s a disrupter, and that scares people up here. They’re used to these insiders, these people that are part of the swamp, and that’s not who Tulsi is. This is a career military officer.”
    “She certainly understands the importance of intelligence. I think what Tulsi is going to bring to the table is she errs on the side of transparency – she’s going to err on the side that she believes that Americans can take the truth, and I think you’re going to see that.”
    “We’re seeing John Ratcliffe already coming out, letting more information loose. I think Tulsi is going to err on that side as well, and that scares the swamp up here, so we’ll see. I’m optimistic. I do think that she’s going to have a little bit of a challenge, but I’m optimistic.”

    MIL OSI USA News –

  • MIL-OSI New Zealand: Animal Welfare – Warmer weather brings increased risks to dogs – NZVA

    Source: NZ Veterinary Association

    Dog owners are being warned to keep their pets away from highly toxic karaka berries and algal blooms this summer, and to contact their veterinarian immediately if they think their dog has swallowed them.
    The New Zealand Veterinary Association Te Pae Kīrehe (NZVA) encourages owners to walk dogs on a leash if toxic algae or karaka berries could be in the vicinity as both can make dogs incredibly ill.
    NZVA Head of Veterinary Services Companion Animal Sally Cory says at this time of year pets are spending more time outdoors and have more access to things that can harm them. “Unfortunately, dogs are attracted to karaka berries and toxic algae because of the strong smell,” she says. “Even small amounts can be dangerous, so if you think your dog has eaten karaka berries or toxic algae, call your veterinarian immediately and they will advise you what to do next.”
    The karaka tree fruits annually between January and April, dropping orange berries containing the alkaloid, karakin, which may be poisonous to dogs. Consumption of the berries by canines – who love their sweet taste – can lead to impaired neurological function, respiratory failure, and even death. Clinical signs can be delayed from between 24 hours and a week or more following ingestion.
    Toxic algae, also known as cyanobacteria, appears in rivers and lakes as black, green, or brown slime on rocks, and as brown or black ‘mats’. Symptoms can develop within 30 minutes and include panting, lethargy, muscle tremors, twitching, and convulsions.
    “When walking your dog near fresh water at this time of year, be mindful if it’s been dry and the water is potentially stagnant, or if it has rained heavily after a dry period as this can cause algae mats to dislodge,” Sally says. “Toxic algae has a strong, musty odour which dogs are attracted to and the toxic reaction can be fast. Remember if humans are advised not to swim somewhere, dogs shouldn’t swim there either.”
    Sally advises dog owners to keep an eye on information provided by local councils as signage may not always be installed at parks, rivers, and lakes. You can look up the potential risks of a destination by visiting Land Air Water Aotearoa.
    Sally also urges puppy and dog owners to make sure their pets are fully vaccinated against parvovirus as cases tend to rise when dogs spend more time in public spaces when the weather is warmer. Dogs can become infected by ingesting the virus through direct contact with contaminated faeces, surfaces, or objects, such as food bowls. The virus can even be transmitted on footwear. Signs of illness usually occur within three to seven days of exposure and may include severe, often bloody diarrhoea; vomiting; lethargy; decreased appetite; fever or low body temperature; rapid dehydration; and in severe cases, death.
    “We have started to see an increase in parvovirus cases already this season,” Sally says. “It is a highly contagious, viral disease, but it is preventable with appropriate vaccination.” Those most at risk are young (six weeks to six months), unvaccinated, or incompletely vaccinated puppies.
    Similarly, vaccinations need to be kept up-to-date for canine cough (kennel cough), an infectious respiratory disease that spreads when dogs are in close contact, such as at the beach, in parks, on walks, and in boarding kennels or daycare facilities. Talk to your veterinarian to ensure your dog is protected against parvovirus and canine cough.
    The summer months also bring the risk of bee sting reactions, incidents of dogs swallowing too much salt water, and grass seeds becoming lodged in ears and between toes, so keep an eye out for these too while out and about enjoying the warmer weather.
    Signs of karaka poisoning include:
    – Vomiting or diarrhoea
    – Abdominal pain
    – Reduced appetite
    – Paralysis of back legs
    – Loss of balance
    – Convulsions
    – Breathing slower than usual (which can lead to paralysis of breathing muscles).
    – If you think your dog has eaten any karaka berries, contact your vet immediately.
    Signs of toxic algae poisoning include:
    – Panting
    – Lethargy
    – Muscle tremors
    – Twitching
    – Convulsions
    – If your dog is showing any of these symptoms after being in contact with a waterway, contact your veterinarian immediately.
    More information on these topics can be found on the NZVA website:

    MIL OSI New Zealand News –

  • MIL-OSI United Kingdom: Reeves: I am going further and faster to kick start the economy

    Source: United Kingdom – Executive Government & Departments

    Chancellor unveils new plans to deliver the Oxford-Cambridge Growth Corridor that will boost the UK economy by up to £78 billion by 2035.

    • Rachel Reeves will today vow to go ‘further and faster’ to deliver the government’s Plan for Change to kick start economic growth and put more pounds in people’s pockets.
    • Chancellor to unveil plans to unleash the potential of the Oxford-Cambridge Growth Corridor that will add up to £78 billion to the UK economy according to industry experts, catalysing growth of UK science and technology.
    • Comes after Chancellor last week announced National Wealth Fund and Office for Investment will take new approaches to spur regional growth across the UK.

    Chancellor Rachel Reeves will today vow to go “further and faster” to kick start the economy, as she unveils new plans to deliver the Oxford-Cambridge Growth Corridor that will boost the UK economy by up to £78 billion by 2035 according to industry experts.

    In a speech in Oxfordshire, the Chancellor will tell regional and business leaders that economic growth is the number one mission of this government and its Plan for Change. She will declare that Britain’s economy has “huge potential” and is at the “forefront of some of the most exciting developments in the world like artificial intelligence and life sciences.”

    She will back the redevelopment of Old Trafford and will review the Green Book – the government’s guidance on appraisal – in order to support decisions on public investment across the country, including outside London and the Southeast.

    The speech comes after the Chancellor last week announced a new approach for the National Wealth Fund (NWF) and the Office for Investment (OfI) to work with local leaders to build pipelines of incoming investment and projects linked to regional growth priorities. This includes the NWF trialling Strategic Partnerships in Greater Manchester, West Yorkshire, West Midlands, and Glasgow City Region and the OfI piloting an approach in the Liverpool City Region and the North East Combined Authority to connect their regions to central government and industry expertise in order to unlock private investment.

    Reeves will say “low growth is not our destiny, but that economic growth will not come without a fight. Without a government that is on the side of working people. Willing to take the right decisions now to change our country’s course for the better.”

    The Chancellor is expected to say: 

    Britain is a country of huge potential. A country of strong communities, with local businesses at their heart.

    We are the forefront of some of the most exciting developments in the world like artificial intelligence and life sciences. We have great companies based here delivering jobs and investment in Britain.

    And we have fundamental strengths – in our history, our language, and our legal system – to compete in a global economy.

    But for too long, that potential has been held back. For too long, we have accepted low expectations, accepted stagnation and accepted the risk of decline. We can do so much better.

    Low growth is not our destiny. But growth will not come without a fight. Without a government that is on the side of working people. Willing to take the right decisions now to change our country’s course for the better.

    That’s what our Plan for Change is about. That is what drives me as Chancellor. And it is what I’m determined to deliver.

    In her speech the Chancellor will announce:

    • The Environment Agency has lifted its objections to a new development around Cambridge that could unlock 4,500 new homes and associated community spaces such as schools and leisure facilities as well as office and laboratory space in Cambridge City Centre. This was only possible as a result of the government working closely with councils and regulators to find creative solutions to unlock growth and address environmental pressures.

    • That the government has agreed for water companies to unlock £7.9bn investment for the next 5 years to improve our water infrastructure and provide a foundation for growth. This includes nine new reservoirs, such as the new Fens Reservoir serving Cambridge and the Abingdon Reservoir near Oxford.

    • Confirming funding towards better transport links in the region including funding for East-West Rail, with new services between Oxford and Milton Keynes this year and upgrading the A428 to reduce journey times between Milton Keynes and Cambridge.

    • Prioritisation of a new Cambridge Cancer Research Hospital as part of the New Hospitals Programme bringing together Cambridge University, Addenbrookes Hospital and Cancer Research UK.

    • Support for the development of new and expanded communities in the Oxford-Cambridge Growth Corridor and a new East Coast Mainline station in Tempsford, to expand the region’s economy.
    • That she welcomes Cambridge University’s proposal for a new large scale innovation hub in the city centre. As the world’s leading science and tech cluster by intensity, Cambridge will play a crucial part in the government’s modern Industrial Strategy.
    • A new Growth Commission for Oxford, inspired by the Cambridge model, to review how best we can unlock and accelerate nationally significant growth for the city and surrounding area.
    • Appointment of Sir Patrick Vallance as Oxford-Cambridge Growth Corridor Champion to provide senior leadership to ensure the Government’s ambitions are delivered. 

    The Chancellor is expected to say:

    Oxford and Cambridge offer huge economic potential for our nation’s growth prospects.

    Just 66 miles apart these cities are home to two of the best universities in the world two of the most intensive innovation clusters in the world and the area is a hub for globally renowned science and technology firms in life sciences, manufacturing, and AI.

    It has the potential to be Europe’s Silicon Valley. The home of British innovation.

    To grow, these world-class companies need world-class talent who should be able to get to work quickly and find somewhere to live in the local area. But to get from Oxford to Cambridge by train takes two and a half hours.

    There is no way to commute directly from towns like Bedford and Milton Keynes to Cambridge by rail. And there is a lack of affordable housing across the region.

    Oxford and Cambridge are two of the least affordable cities in the UK. In other words, the demand is there but there are far too many supply side constraints on economic growth in the region.

    Designed to take advantage of the region’s unique strengths and potential, the announcements are further evidence of the government’s modern Industrial Strategy in action as it seeks to create the right conditions to increase investment in our leading growth sectors like life sciences, artificial intelligence and advanced manufacturing.

    She will add:

    Taken together, these announcements show that for the first time a government is providing real leadership to deliver this project with a clear strategy for the entire region backed by funding for the housing and infrastructure we so badly need.

    The speech comes after the Chancellor last week announced a package of investment reforms to spur regional growth across the UK. Rachel Reeves set out a new approach for the National Wealth Fund (NWF) and the Office for Investment (OfI) to work with local leaders to build pipelines of incoming investment and projects linked to regional growth priorities. Putting local knowledge and leadership at the forefront, there will be tailored strategies for each region to ensure investment matches local needs and drives sustainable growth. Putting the government’s Plan for Change into action, the Chancellor set out that the goal is to harness growth everywhere to rebuild Britain and usher in a decade of national renewal. Measures included the NWF trialling Strategic Partnerships in Greater Manchester, West Yorkshire, West Midlands, and Glasgow City Region and the OfI piloting an approach in the Liverpool City Region and the North East Combined Authority to connect their regions to central government and industry expertise in order to unlock private investment.

    Science Minister, Lord Patrick Vallance said: 

    The UK has all the ingredients to replicate the success of Silicon Valley or the Boston Cluster but for too long has been constrained by short termism and a lack of direction.

    This government’s Plan for Change will see an end to that defeatism. I look forward to working with local leaders to fulfil the Oxford-Cambridge corridor’s potential by building on its existing strengths in academia, life sciences, semiconductors, AI and green technology amongst others.

    Together we will build the infrastructure and partnerships needed to join up this region’s academia, investors and business so that we can boost growth, deliver innovations and create new jobs that improve all our lives.

    Transport Secretary, Heidi Alexander said:

    Well connected communities are a cornerstone for growth. East West Rail will not only provide better links and lasting benefits to Oxford and Cambridge, but to all the surrounding areas.

    I’m also delighted to announce a brand new station at Tempsford, which will be game changing for the region – allowing a new community and businesses to grow, unlocking faster and smoother access to opportunities, and delivering on the Government’s Plan for Change.

    More details

    • Yesterday, Moderna completed the build for their new vaccine production and R&D site in Harwell, Oxfordshire. They have committed to invest over £1 billion in R&D in the UK, strengthening our position as a global leader in biopharmaceutical innovation.
    • £78 billion added to the UK economy. Source: Public First research for the Oxford-Cambridge Supercluster Board (2025).
    • Dr Andy Williams, Chair of the Oxford-Cambridge Supercluster Board said: 

    The announcements today are extremely positive for the region and for the country. As Chair of the OxCam Supercluster Board, which comprises 45 members across business, academia, and investors, we know that the region has the potential to deliver truly remarkable growth in the coming decade and beyond, as evidenced by the research published this week. Achieving £78 billion in cumulative economic value by 2035 requires us to work dynamically and pro-actively across government, the private sector, educational institutions, and the investment community, to fully harness OxCam’s strengths and address its weaknesses. With the experience and knowledge of Sir Patrick Vallance leading this effort, we are excited by the opportunity to co-design a policy prospectus that will allow the OxCam Growth Corridor to realise its potential as a global centre for science and innovation.

    • Dipesh J. Shah OBE, Chair of the Oxford to Cambridge Partnership said: 

    I welcome the Chancellor’s drive to accelerate growth in the Oxford to Cambridge corridor and her support for strategic investments in enabling infrastructure. The region houses internationally acclaimed clusters of innovation in each of the growth sectors for the nation. Already one of the world’s great science powerhouses, the region’s full potential will rely on connecting its incredible ecosystems of businesses, places and communities. Investments announced today will spur more and will help local leaders to deliver on their ambitious plans for their communities.

    • Professor Alistair Fitt, Chair of Arc Universities Group and Vice-Chancellor Oxford Brookes University said:

    This region hosts a great diversity and scale of universities. Together we offer a wide range of key contributions: globally renowned research brilliance, the powerhouse of skills provision provided by cutting edge teaching, world class knowledge transfer and commercialisation. Our universities, working in close partnership, in alliance with others – particular the private sector – are organised into the Arc Universities Group.  We stand ready for the challenge. We welcome the oversight and experience that the leadership of Sir Patrick Vallance brings to the region, and we look forward to helping deliver the Chancellor’s aspirations for growth.

    • Darius Hughes, UK General Manager for Moderna said:

    We are proud to call Oxfordshire our home with the recent completion of construction of the Moderna Innovation and Technology Centre in Harwell. Today’s announcement demonstrates the government’s commitment to growth and innovation, and we look forward to delivering British-made vaccines to the UK public, advancing cutting-edge research, and strengthening partnerships in this globally significant region.

    • Steve Bates, CEO of the UK Bioindustry Association said:

    The UK is a global leader in biotech innovation and attracts the most venture capital in Europe. New figures we’ve published this week show that biotech is a vibrant growth sector of the UK economy with an exceptional ability to attract global investment. Delivering the infrastructure needed to support the growth at pace – especially in the Oxford Cambridge growth corridor- is key to the success of our sector.

    • The government is continuing to work with local partners to deliver sustainable growth in Cambridge, with the additional homes and infrastructure the city needs. Peter Freeman and the Cambridge Growth Company are building the evidence base for an infrastructure-first growth strategy to realise the full potential of Cambridge and improve lives for residents.
    • The Chancellor today announced that delivery of a new East Coast Mainline station in Tempsford will be accelerated by 3-5 years. The station will link services directly to London, with services in under an hour. It will eventually also be an interchange with the East West Rail station.  
    • The A428 (Black Cat to Caxton Gibbet) scheme will improve journeys between Milton Keynes, Bedford and Cambridge. The scheme will see a new 10-mile dual carriageway delivered, as well as three grade separated junctions, three tier at Black Cat roundabout (A1/A421) and two tier at Cambridge Road (B1428) and Caxton Gibbet (A428/A1198) junctions, respectively. Main construction began in December 2023 and the road is expected to open in 2027.
    • The Environment Agency have lifted their opposition to new development around Cambridge (Waterbeach and the Beehive centre). This unlocks the delivery of 4,500 new homes and associated community spaces such as schools and leisure facilities as well as office and laboratory space in Cambridge City Centre. This demonstrates how the government, councils, and regulators are working together to find solutions that unlock growth and address environmental pressures.
    • The government has agreed water companies’ water resources management plans, including Cambridge Water’s, unlocking a now-confirmed £7.9bn investment in water resources in the next 5 years to provide a foundation for growth and improving our water infrastructure. These plans include nine new reservoirs, including the new Fens Reservoir serving Cambridge to South East Strategic Reservoir Option (Abingdon Reservoir) near Oxford.
    • The Chancellor will announce a new Growth Commission for Oxford, similar to the Cambridge Growth Company to bring together key stakeholders across the city and review how best to tackle the barriers that are constraining development of new housing and infrastructure to accelerate growth in the city.
    • AI Growth Zones, as recommended in the AI Action Plan launched by the PM earlier this month, are designated areas designed to fast-track the development of AI-focused data centres and supporting infrastructure. By concentrating government support on planning and energy, AIGZs aim to attract significant private investment, accelerate the build-out of critical AI infrastructure, and drive local economic regeneration. The first AI Growth Zone will be in Culham, Oxfordshire and the Chancellor today announced a ‘call for expressions of interest’ from regional and local authorities and industry, to inform the next stage of the AI Growth Zones programme. This will help us understand early opportunities and inform the next stage of the programme in what the government regards as a key growth sector in its modern Industrial Strategy.

    • On Monday 20th January the Health Secretary announced the Cambridge Cancer Research Hospital is being prioritised for investment as part of wave 1 of the New Hospital Programme. This scheme will improve cancer survival rates by centralising Cambridge University Hospital cancer services under one roof and will further improve the proposition for the life sciences sector in the region, with AstraZeneca and CRUK researchers co-located at the facility, integrating the clinical and research models of cancer services. In doing so it will help create three new research institutes to be integrated with NHS clinical care helping to provide 10 new clinical trials per year and foster increased collaboration between top scientists and clinicians.

    • The Chancellor will welcome Cambridge University’s plans for a new largescale innovation hub in the heart of the city. The Global Innovation Index (GII) 2024 has ranked Cambridge as the world’s leading science and technological cluster by intensity for the third consecutive year.

    Updates to this page

    Published 28 January 2025

    MIL OSI United Kingdom –

  • MIL-OSI USA: Tuberville Supporting Elimination of DEI, Restoration of Lethality in Armed Forces

    US Senate News:

    Source: United States Senator for Alabama Tommy Tuberville
    WASHINGTON – Today, U.S. Senator Tommy Tuberville (R-AL) issued a statement in support of President Donald Trump’s latest executive orders restoring lethality to the United States Armed Forces.
    “For the past four years, I have sounded the alarm about Joe Biden and the far-left, progressive Democrats politicizing our military,” said Senator Tuberville. “As a result, recruitment has fallen to the lowest levels since before World War II. We need our military to be a fighting machine, not a playground for Democrats’ culture war. Thankfully, change is here. Yesterday’s executive orders from President Donald Trump eliminate DEI in the military, reinstate service members discharged for refusing the COVID vaccine, and ensure military standards are updated to prioritize readiness, restore lethality, and build confidence in our Armed Forces. With President Trump and Secretary Hegseth at the helm, our military will be 100% focused on protecting our country and putting America First on the world stage.”
    MORE:
    Tuberville: “We need a military that is 100% focused on protecting our country and enhancing national security.”
    ICYMI: Tuberville op-ed: “Biden is Infecting Our Military With Woke Politics While the World Implodes”
    Tuberville Questioned Army Officials on Lasting Effects of Vaccine Policy on the Military
    Tuberville, Colleagues Help Secure Provision To Protect Servicemembers From COVID Vaccine Mandate In 2023 NDAA
    Tuberville Questions Pentagon about COVID Vaccine Military Discharge
    Tuberville Demands Answers on Military’s Vaccine Mandate
    Senator Tommy Tuberville represents Alabama in the United States Senate and is a member of the Senate Armed Services, Agriculture, Veterans’ Affairs, HELP, and Aging Committees.

    MIL OSI USA News –

  • MIL-OSI United Nations: World News in Brief: Children killed in Darfur hospital attack, date set for US climate pact withdrawal, WHO leads call to fight neglected diseases

    Source: United Nations 4

    Peace and Security

    At least one girl and three boys were killed, and three boys injured, during an attack on the Saudi Hospital in the besieged Sudanese city of El Fasher, North Darfur, on Friday. 

    The children were among the patients being treated in the hospital’s emergency ward for injuries from previous bombings in the area, said the UN Children’s Fund, UNICEF.

    “This heinous attack is a blatant violation of children’s rights. Children are being killed and injured in the very places where they should be safest from harm,” said UNICEF Executive Director Catherine Russell.

    “Such attacks exacerbate the dire situation for children and families who are trapped in areas affected by conflict, insecurity, and lack of protection.”

    70 per cent of hospitals out of action

    In Sudan, over 70 per cent of hospitals in conflict-affected areas are currently non-operational due to damage, destruction, lack of supplies, or being used as shelters.

    The delivery of medical supplies, vaccines, and routine immunisation has been hindered by ongoing security concerns and lack of access, worsening the humanitarian crisis and putting countless lives, especially those of children, at significant risk.

    Under International Humanitarian Law, hospitals enjoy special protection and must not be targeted. Attacks on them undermine the essential care and relief the facilities provide to civilians, including children. All parties to the conflict have an obligation to ensure the protection of civilians, including children, and refrain from any actions that could impede access to life-saving medical services.

    “Continued attacks on health facilities endanger children’s lives and restrict their access to lifesaving medical care, which can have immediate and long-term impacts on their health,” said Ms. Russell. “The violence must end now. Children in Sudan cannot wait any longer.”

    US with pull out of Paris Agreement 27 January next year

    The United States has officially notified the Secretary-General of its withdrawal from the Paris Climate Agreement, effective 27 January 2026, UN Spokesperson Stéphane Dujarric said on Tuesday.

    The historic accord reached by 193 countries in December 2015 in a bid to keep temperature rises to below 1.5°C above pre-industrial levels, was signed by the US on 22 April 2016.

    During the first Trump administration the US withdrew from the Agreement effective 4 November 2020, before his successor took the country back into the accord on 19 February 2021.

    Fight continues against global warming

    The UN Spokesperson said the latest withdrawal would not lead to any slowdown in the UN’s efforts to combat climate change.

    “We reaffirm our commitment to the Paris Agreement and to support all effective efforts to limit the rise in global temperature to 1.5 degrees Celsius,” said Mr. Dujarric.

    The international community continues to work towards the goals set by the Agreement, despite the US’s decision to withdraw.

    UN health agency leads call to fight neglected disease scourge

    Health news now, and an appeal from the UN World Health Organization (WHO) for concerted action to tackle neglected tropical diseases, which impact more than one billion people – often with devastating health, social and economic consequences.

    Every year, around 800 to 900 million people are treated for at least one neglected tropical disease, according to the UN health agency, which warned that global warming has emerged as a threat in this field of medicine.

    Long list

    The list of tropical diseases is a long one and includes Buruli ulcer, Chagas disease, dengue, chikungunya and dracunculiasis. They tend to thrive among vulnerable people who live in poverty and are caused by viruses, bacteria, parasites, fungi and toxins.

    Progress in tackling these diseases remains hampered by a lack of investment and conflict, the WHO said, ahead of World Neglected Tropical Disease Day on Thursday.

    Today, 54 countries have successfully eliminated at least one neglected tropical disease; WHO’s goal is for 100 countries to do the same by 2030. 

    MIL OSI United Nations News –

  • MIL-OSI Europe: Briefing – Foot and mouth disease: Fresh cause for concern – 28-01-2025

    Source: European Parliament

    It has been 14 years since the last outbreak of foot and mouth disease (FMD) in a European Union (EU) country. However, three water buffaloes have recently tested positive for the disease in Germany. While FMD poses no risk to human health, it is a highly contagious viral disease that can affect various cloven-hoofed animals. The speed with which the disease spreads makes it essential to cull all animals hosted on the affected farm once an outbreak is detected, and to apply strict biosecurity measures. This results in significant economic losses. As a result of the 2001 outbreak in the United Kingdom (UK), over 6 million animals were culled in one year, costing more than £3 billion (more than €6.5 billion at current prices) in public expenditure and having a huge impact on the tourism sector. The EU has legislation in place outlining rules for the prevention and control of animal diseases such as FMD, including a notification system integrated into the World Animal Health Information System to facilitate a coordinated approach. The European Commission also cooperates with the United Nations Food and Agriculture Organization (FAO) to fight the spread of the disease. Since 1990, the use of preventive vaccines against FMD has been prohibited in the EU, except for in certain cases and in emergencies. Although conventional FMD vaccines protect livestock from developing the disease, vaccinated animals may still become infected and carry the disease.

    MIL OSI Europe News –

  • MIL-OSI Europe: Answer to a written question – DANA in Spain and the risk of medicine and vaccine shortages – E-002481/2024(ASW)

    Source: European Parliament

    The European Medicines Agency (EMA), together with the Member States, continuously monitors and investigates signals of potential supply disruptions escalated to EU level by national competent authorities to prevent their occurrence and mitigate their effects as far as possible.

    The potential impact of the situation in Spain on the supply of medicinal products is closely monitored. Thus far, no critical shortage requiring EU coordination actions has been identified in this context.

    In the context of the flood emergency and upon request from the Spanish authorities, the EU Copernicus satellite mapping system[1] was activated on 29 October 2024, and the EU Civil Protection Mechanism[2], on 8 November 2024.

    As a result, 83 maps were produced, and several Member States offered in-kind assistance, in the form of heavy vehicles and pumps. The Commission deployed two liaison officers to help coordinate the assistance. The EU’s strategic reserve, rescEU,[3] was not mobilised as the requests were fulfilled by the offers of Member States.

    A virtual warehouse for data on vaccine needs and stocks has not been set up yet, apart from the existing IT tool CECIS 2.0, in the area of civil protection.

    As part of the implementation of EMA’s extended mandate[4], the European Shortages Monitoring Platform, launched in November 2024, will be used to report shortages and monitor supply, demand, and stock levels of medicinal products for preparedness activities, and during a public health emergency or major event.

    As part of the pharmaceutical reform[5], the Commission has proposed to further expand the platform to cover structural shortages and security of supply of critical medicines.

    • [1] https://emergency.copernicus.eu/mapping/#zoom=2&lat=13.56036&lon=33.82273&layers=0BT00
    • [2] https://civil-protection-humanitarian-aid.ec.europa.eu/what/civil-protection/eu-civil-protection-mechanism_en
    • [3] https://civil-protection-humanitarian-aid.ec.europa.eu/what/civil-protection/resceu_en
    • [4] http://data.europa.eu/eli/reg/2022/123/oj
    • [5] https://health.ec.europa.eu/medicinal-products/pharmaceutical-strategy-europe/reform-eu-pharmaceutical-legislation_en

    MIL OSI Europe News –

  • MIL-OSI Global: Five reasons why vertical farming is still the future, despite all the recent business failures

    Source: The Conversation – UK – By Gail Taylor, Dean of Life Sciences, UCL

    Don’t believe the tripe. Amorn Suriyan

    Plant factories are failing, with multiple companies closing or going bankrupt in recent months. This includes the largest vertical farm on the planet, in Compton, Los Angeles.

    Owned by San Francisco-based startup Plenty, the farm opened in 2023 to grow salads in partnership with Walmart. It was mothballed at the end of 2024, with the company citing the rising cost of energy in California as a major problem.

    Despite raising over US$1 billion (£802 million) from investors, the company’s value has reportedly plummeted from US$1.9 billion to below US$15 million. It now aims to focus solely on strawberry production in Virginia.

    New York-based Bowery Farming also halted all operations in late 2024, having previously being valued at US$2.3 billion. Fellow American vertical farmers AeroFarms, Kalera and AppHarvest have similarly filed for bankruptcy in the past two years, as has the UK’s Growing Underground, among various others.

    Clearly these are major setbacks. Year-round illuminated greenhouses and stacked, controlled-environment warehouses for producing food have been hailed as a sustainable alternative to traditional farming, promising fresh food close to populations.

    This reduces the need for transportation, which together with other issues in traditional farming such as soil degradation and forest clearing see it contributing around 20% of the greenhouse gases that lead to planetary warming and climate change.

    Multiple new indoor-farming companies sprang into life in the past decade, driven by significant venture capital. They harnessed the latest in LED lighting and hydroponic and aeroponic growing systems, using land and water ten to 100 times more efficiently than in a field and with far fewer pesticides.

    Initially developed to grow leafy greens and microgreens, these farms have more recently turned to higher value produce including herbs, strawberries, tomatoes and grapes.

    Grow, baby, grow.
    Gorodenkoff

    Among the reasons for the business failures are rising energy costs; the fact that traditional farming is cheaper, making it hard to compete on price; and the fact that rising interest rates have made financing more expensive.

    Together with other challenges such as high energy consumption and finding enough skilled labour, many opponents are writing this sector off as a fad that is unlikely to ever make a big impact on food security.

    This ignores success stories, such as JFC and Grow-up Farms, which are regular suppliers to the UK supermarkets. But more broadly, there are various reasons why the critics are likely to be wrong:

    1. We’re still early

    Vertical farming has been proving itself by “learning by doing” for the past decade. Kicked off by Nasa space scientists seeking to grow food in hostile environments with zero gravity and heavy radiation, this field is still highly experimental.

    New technologies like this one often conform to the Gartner hype cycle, where big initial expectations are rarely met, leading to a trough of disillusionment. Following this, the benefits start to crystallise as new players enter the market and mainstream adoption begins.

    Vertical farming is only a very small proportion of total farming, but it looks very likely to flourish given the need to reduce greenhouse-gas emissions, and the threats to food security from climate change and population growth. In addition, the costs are likely to be reduced by the arrival of much more renewable energy at cheaper prices in years to come.

    2. Heavy plant demand is coming

    Society stands on the edge of an unprecedented transformation as it shifts away from fossil fuels. We’re going to move to a circular bioeconomy, in which green plants will be central as feedstocks for everything from aviation fuels to alternative proteins to vaccine production to plant-based plastics.

    All this means greater pressure on land resources for food production, and an enhanced need for vertically stacked agriculture that recycles water and nutrients and requires fewer chemicals.

    3. Science is on its side

    Unexpected scientific discoveries continue to drive vertical farming. For example, tunable wavelength LEDs have shown that certain spectral bands can affect crops profoundly.

    Far-red light, which is just beyond visible red light, promotes growth and flowering, raising lettuce yields by 30%, for example. Blue light can improve shelf-life and nutritional quality, even enhancing certain plant chemicals known to help prevent cancers.

    The significance of these discoveries has yet to be fully realised, but by the complete control of the farming environment that indoor farming makes possible, we will be able to more easily tailor food quality for the betterment of people and the planet.

    4. It’s horses for courses

    Growing leafy greens indoors in California, as Plenty did, was always going to be challenging. This is the state where they invented the iceberg lettuce, where wall-to-wall sunshine and even temperatures enable farmers to grow enough salad greens to supply the whole of the US.

    Contrast Singapore, where only 6% of fresh produce is locally grown. This has prompted the government to develop the “30 x 30” goal to supply 30% of nutritional needs by 2030, with vertical farming a key part of the strategy.

    Similarly the United Arab Emirates imports over 90% of its food, and is looking towards a future that includes vertical farming. The UK and much of northern Europe, where the outdoor growing season is short and land is limited, can also benefit from these technologies (and indeed, do already).

    It’s a different story in Singapore.
    PrasitRodphan

    5. Baby and bathwater

    Unlike the cutting-edge LED-illuminated, stacked warehouses, intensive hydroponic greenhouses have been operating commercially for decades. The Netherlands leads the way in supplying year-round fresh produce from these structures, and is now the second biggest food exporter in the world.

    Even in the UK, its common for such greenhouses to supply potted herbs, tomatoes and strawberries all year round.

    These are a half-way house to vertical farming, and are also likely to be in greater demand in the coming decades. They could well extend their reach to supply fresh nutritious food to places where food security may be particularly challenged, such as Africa, south Asia and the Middle East.

    Gail Taylor has received funding for research on vertical farming from the John B. Orr Endowment from the University of California, Davis and gift funding from the company, Plenty. Between 2021 and 2024 she was a member of the Scientific Advisory Board for the company Plantible Foods.

    – ref. Five reasons why vertical farming is still the future, despite all the recent business failures – https://theconversation.com/five-reasons-why-vertical-farming-is-still-the-future-despite-all-the-recent-business-failures-248270

    MIL OSI – Global Reports –

  • MIL-OSI: Eagle Bancorp Montana Earns $3.4 Million, or $0.44 per Diluted Share, in the Fourth Quarter of 2024 and $9.8 Million, or $1.24 per Diluted Share for the Year 2024; Declares Quarterly Cash Dividend of $0.1425 Per Share

    Source: GlobeNewswire (MIL-OSI)

    HELENA, Mont., Jan. 28, 2025 (GLOBE NEWSWIRE) — Eagle Bancorp Montana, Inc. (NASDAQ: EBMT), (the “Company,” “Eagle”), the holding company of Opportunity Bank of Montana (the “Bank”), today reported net income of $3.4 million, or $0.44 per diluted share, in the fourth quarter of 2024, compared to $2.7 million, or $0.34 per diluted share, in the preceding quarter, and $2.2 million, or $0.28 per diluted share, in the fourth quarter of 2023. For the year ended December 31, 2024, net income was $9.8 million, or $1.24 per diluted share, compared to $10.1 million, or $1.29 per diluted share, in 2023.

    Eagle’s board of directors declared a quarterly cash dividend of $0.1425 per share on January 23, 2025. The dividend will be payable March 7, 2025, to shareholders of record February 14, 2025. The current dividend represents an annualized yield of 3.93% based on recent market prices.

    “Eagle’s fourth quarter operating results were highlighted by strong quarterly deposit growth, sound revenue generation, and net interest margin expansion,” said Laura F. Clark, President and CEO. “We continue to maintain a stable core deposit base, with non-CDs representing 72.4% of total deposits at year end. Additionally, we continue to maintain quality credit. While loan growth has moderated in recent quarters, we are anticipating steady single-digit loan growth in the year ahead.”

    Fourth Quarter 2024 Highlights (at or for the three-month period ended December 31, 2024, except where noted):

    • Net income increased 26.7% to $3.4 million, or $0.44 per diluted share, in the fourth quarter of 2024, compared to $2.7 million, or $0.34 per diluted share, in the preceding quarter, and increased 58.6% compared to $2.2 million, or $0.28 per diluted share, in the fourth quarter a year ago.
    • Net interest margin (“NIM”) was 3.59% in the fourth quarter of 2024, a 25 basis point increase compared to 3.34% in the preceding quarter and a 27 basis point increase compared to the fourth quarter a year ago.
    • Revenues (net interest income before the provision for credit losses, plus noninterest income) increased 2.8% to $21.4 million in the fourth quarter of 2024, compared to $20.8 million in the preceding quarter and increased 1.7% compared to $21.0 million in the fourth quarter a year ago.
    • Total loans increased 2.4% to $1.52 billion, at December 31, 2024, compared to $1.48 billion a year earlier, and decreased 0.9% compared to $1.53 billion at September 30, 2024.
    • Total deposits increased $46.0 million or 2.8% to $1.68 billion at December 31, 2024, compared to a year earlier, and increased $30.7 million or 1.9%, compared to September 30, 2024.
    • The allowance for credit losses represented 1.11% of portfolio loans and 437.7% of nonperforming loans at December 31, 2024, compared to 1.11% of portfolio loans and 195.2% of nonperforming loans at December 31, 2023.
    • The Company’s available borrowing capacity was approximately $404.0 million at December 31, 2024, compared to $398.5 million at December 31, 2023.
      December 31, 2024 December 31, 2023
    (Dollars in thousands)  Borrowings Outstanding    Remaining Borrowing Capacity    Borrowings Outstanding    Remaining Borrowing Capacity
    Federal Home Loan Bank advances $ 140,930   $ 276,664   $ 175,737   $ 266,017
    Federal Reserve Bank discount window   –     27,349     –     32,472
    Correspondent bank lines of credit   –     100,000     –     100,000
    Total $ 140,930   $ 404,013   $ 175,737   $ 398,489
             
    • The Company paid a quarterly cash dividend in the fourth quarter of $0.1425 per share on December 6, 2024, to shareholders of record November 15, 2024.

    Balance Sheet Results
    Eagle’s total assets increased 1.3% to $2.10 billion at December 31, 2024, compared to $2.08 billion a year ago, and decreased 2.0% compared to $2.15 billion three months earlier. The investment securities portfolio totaled $292.6 million at December 31, 2024, compared to $318.3 million a year ago, and $307.0 million at September 30, 2024.

    Eagle originated $68.1 million in new residential mortgages during the quarter and sold $64.0 million in residential mortgages, with an average gross margin on sale of mortgage loans of approximately 3.18%. This production compares to residential mortgage originations of $58.0 million in the preceding quarter with sales of $51.0 million and an average gross margin on sale of mortgage loans of approximately 3.31%. Mortgage volumes remain low as rates have continued to be elevated relative to rates on existing mortgages.

    Total loans increased $36.2 million, or 2.4%, compared to a year ago, and decreased $14.0 million, or 0.9%, from three months earlier. Commercial real estate loans increased 6.1% to $646.0 million at December 31, 2024, compared to $608.7 million a year earlier. Commercial real estate loans were comprised of 71.4% non-owner occupied and 28.6% owner occupied at December 31, 2024. Agricultural and farmland loans increased 4.9% to $281.0 million at December 31, 2024, compared to $267.9 million a year earlier. Residential mortgage loans decreased 1.8% to $153.7 million, compared to $156.6 million a year earlier. Commercial loans increased 8.5% to $144.0 million, compared to $132.7 million a year ago. Commercial construction and development loans decreased 21.5% to $124.2 million, compared to $158.1 million a year ago. Home equity loans increased 12.2% to $97.5 million, residential construction loans increased 5.2% to $45.7 million, and consumer loans decreased 5.4% to $28.5 million, compared to a year ago.

    “Similar to other community banks, our deposit mix has shifted towards higher yielding deposits over the last several quarters due to the higher interest rate environment. However, the recent Fed rate cuts have started to ease deposit pricing, and we anticipate this will continue as we move through this next rate cycle,” said Miranda Spaulding, CFO.

    Total deposits increased to $1.68 billion at December 31, 2024, compared to $1.64 billion at December 31, 2023, and $1.65 billion at September 30, 2024. Noninterest-bearing checking accounts represented 24.9%, interest-bearing checking accounts represented 13.2%, savings accounts represented 12.5%, money market accounts comprised 21.8% and time certificates of deposit made up 27.6% of the total deposit portfolio at December 31, 2024. There were no brokered certificates at December 31, 2024, compared to $72.2 million at December 31, 2023, and $22.1 million at September 30, 2024. The average cost of total deposits was 1.71% in the fourth quarter of 2024, compared to 1.76% in the preceding quarter and 1.49% in the fourth quarter of 2023. The estimated amount of uninsured deposits was approximately $323.0 million, or 19% of total deposits, at December 31, 2024, compared to $307.0 million, or 18% of total deposits, at September 30, 2024.

    Shareholders’ equity was $174.8 million at December 31, 2024, compared to $169.3 million a year earlier and $177.7 million three months earlier. Book value per share was $21.77 at December 31, 2024, compared to $21.11 a year earlier and $22.17 three months earlier. Tangible book value per share, a non-GAAP financial measure calculated by dividing shareholders’ equity, less goodwill and core deposit intangible, by common shares outstanding, was $16.88 at December 31, 2024, compared to $16.05 a year earlier and $17.23 three months earlier.

    Operating Results
    “The higher yields on interest earning assets combined with a lower cost of funds contributed to our 25 basis point NIM expansion during the quarter, compared to the preceding quarter,” said Spaulding. “We anticipate additional improvement in our cost of funds over the next several quarters.”

    Eagle’s NIM was 3.59% in the fourth quarter of 2024, a 25 basis point increase compared to 3.34% in the preceding quarter and a 27 basis point improvement compared to the fourth quarter a year ago. The interest accretion on acquired loans totaled $161,000 and resulted in a four basis-point increase in the NIM during the fourth quarter of 2024, compared to $167,000 and a three basis-point increase in the NIM during the preceding quarter. Funding costs for the fourth quarter of 2024 were 2.69%, compared to 2.89% in the third quarter of 2024 and 2.58% in the fourth quarter of 2023. Average yields on interest earning assets for the fourth quarter of 2024 increased to 5.70%, compared to 5.66% in the third quarter of 2024 and 5.36% in the fourth quarter a year ago. For the year, the NIM was 3.42% compared to 3.51% for 2023.

    Net interest income, before the provision for credit losses, increased 6.3% to $16.8 million in the fourth quarter of 2024, compared to $15.8 million in the third quarter of 2024, and increased 10.5% compared to $15.2 million in the fourth quarter of 2023. For the year, net interest income increased 1.5% to $63.4 million, compared to $62.5 million in 2023.

    Fourth quarter revenues increased 2.8% to $21.4 million, compared to $20.8 million in the preceding quarter and increased 1.7% compared to $21.0 million in the fourth quarter a year ago. For the year 2024, revenues were $81.2 million, compared to $85.2 million in 2023. The decrease compared to a year ago was largely due to lower volumes in mortgage banking activity.

    Total noninterest income decreased 8.2% to $4.6 million in the fourth quarter of 2024, compared to $5.0 million in the preceding quarter, and decreased 21.3% compared to $5.8 million in the fourth quarter a year ago. The decrease compared to the preceding quarter was largely due to income from bank owned life insurance of $724,000 recorded during the third quarter of 2024. Net mortgage banking income, the largest component of noninterest income, totaled $2.8 million in the fourth quarter of 2024, compared to $2.6 million in the preceding quarter and $3.7 million in the fourth quarter a year ago. This decrease compared to the fourth quarter a year ago was largely driven by a decline in net gain on sale of mortgage loans, which was impacted by lower mortgage loan volumes. For the year, noninterest income decreased 21.8% to $17.8 million, compared to $22.7 million in 2023. Net mortgage banking income decreased 33.1% to $10.0 million in 2024, compared to $15.0 million in 2023. These decreases were driven by a decline in net gain on sale of mortgage loans.

    Eagle’s fourth quarter noninterest expense was $17.7 million, an increase of 2.5% compared to $17.3 million in the preceding quarter and a 6.3% decrease compared to $18.9 million in the fourth quarter a year ago. Lower salaries and employee benefits contributed to the decrease compared to the year ago quarter. For the year, noninterest expense decreased 3.9% to $69.3 million, compared to $72.1 million in 2023.

    For the fourth quarter of 2024, the Company recorded income tax expense of $269,000. This compared to income tax expense of $529,000 in the preceding quarter and an income tax benefit of $315,000 in the fourth quarter of 2023. The effective tax rate for the year was 14.2% compared to 13.7% for the prior year and is due to the increase in proportion of tax-exempt income compared to pretax earnings, as well as tax credits from investments in low-income housing tax credit projects.

    Credit Quality
    Due to muted loan growth and positive economic factors within the CECL modeling, Eagle recorded a recapture in its provision for credit losses of $36,000 during the fourth quarter of 2024. This compared to a $277,000 provision for credit losses in the preceding quarter and $270,000 in the fourth quarter a year ago. The allowance for credit losses represented 437.7% of nonperforming loans at December 31, 2024, compared to 356.7% three months earlier and 195.2% a year earlier. Nonperforming loans were $3.9 million at December 31, 2024, $4.8 million at September 30, 2024, and $8.4 million a year earlier. Net loan charge-offs totaled $44,000 in the fourth quarter of 2024, compared to net loan charge-offs of $17,000 in the preceding quarter and net loan charge-offs of $10,000 in the fourth quarter a year ago. The allowance for credit losses was $16.9 million, or 1.11% of total loans, at December 31, 2024, compared to $17.1 million, or 1.12% of total loans, at September 30, 2024, and $16.4 million, or 1.11% of total loans, a year ago.

    Capital Management
    The ratio of tangible common shareholders’ equity (shareholders’ equity, less goodwill and core deposit intangible) to tangible assets (total assets, less goodwill and core deposit intangible) was 6.57% at December 31, 2024, up from 6.32% a year ago and 6.56% three months earlier. This ratio is a non-GAAP financial measure. For the most comparable GAAP financial measure, see “Reconciliation of Non-GAAP Financial Measures” below. As of December 31, 2024, the Bank’s regulatory capital was in excess of all applicable regulatory requirements and is deemed well capitalized. The Bank’s Tier 1 capital to adjusted total average assets was 10.07% as of December 31, 2024.

    About the Company
    Eagle Bancorp Montana, Inc. is a bank holding company headquartered in Helena, Montana, and is the holding company of Opportunity Bank of Montana, a community bank established in 1922 that serves consumers and small businesses in Montana through 29 banking offices. Additional information is available on the Bank’s website at www.opportunitybank.com. The shares of Eagle Bancorp Montana, Inc. are traded on the NASDAQ Global Market under the symbol “EBMT.”

    Forward Looking Statements
    This release may contain certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and may be identified by the use of such words as “believe,” “will” “expect,” “anticipate,” “should,” “planned,” “estimated,” and “potential.” These forward-looking statements include, but are not limited to statements of our goals, intentions, expectations and anticipations; statements regarding our business plans, prospects, mergers, growth and operating strategies; statements regarding the asset quality of our loan and investment portfolios; and estimates of our risks and future costs and benefits. These forward-looking statements are based on current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. These factors include, but are not limited to, changes in laws or government regulations or policies affecting financial institutions, including changes in regulatory fees and capital requirements; general economic conditions and political events, either nationally or in our market areas, that are worse than expected; the emergence or continuation of widespread health emergencies or pandemics, including but not limited to vaccine efficacy and immunization rates, new variants, steps taken by governmental and other authorities to contain, mitigate and combat the pandemic, adverse effects on our employees, customers and third-party service providers, the increase in cyberattacks in the current work-from-home environment; the impact of volatility in the U.S. banking industry, including the associated impact of any regulatory changes or other mitigation efforts taken by governmental agencies in response thereto; the impact of any new regulatory, policy or enforcement developments resulting from the change in U.S. presidential administration; the possibility that future credit losses may be higher than currently expected due to changes in economic assumptions, customer behavior, adverse developments with respect to U.S. economic conditions and other uncertainties, including the impact of supply chain disruptions, inflationary pressures and labor shortages on economic conditions and our business; an inability to access capital markets or maintain deposits or borrowing costs; competition among banks, financial holding companies and other traditional and non-traditional financial service providers; loan demand or residential and commercial real estate values in Montana; the concentration of our business in Montana; our ability to continue to increase and manage our commercial real estate, commercial business and agricultural loans; the costs and effects of legal, compliance and regulatory actions, changes and developments, including the initiation and resolution of legal proceedings (including any securities, bank operations, consumer or employee litigation); inflation and changes in the interest rate environment that reduce our margins or reduce the fair value of financial instruments; adverse changes in the securities markets that lead to impairment in the value of our investment securities and goodwill; other economic, governmental, competitive, regulatory and technological factors that may affect our operations; our ability to implement new technologies and maintain secure and reliable technology systems including those that involve the Bank’s third-party vendors and service providers; cyber incidents, or theft or loss of Company or customer data or money; our ability to appropriately address social, environmental, and sustainability concerns that may arise from our business activities; the effect of our recent or future acquisitions, including the failure to achieve expected revenue growth and/or expense savings, the failure to effectively integrate their operations, the outcome of any legal proceedings and the diversion of management time on issues related to the integration.

    Because of these and other uncertainties, our actual future results may be materially different from the results indicated by these forward-looking statements. All information set forth in this press release is current as of the date of this release and the company undertakes no duty or obligation to update this information.

    Use of Non-GAAP Financial Measures
    In addition to results presented in accordance with generally accepted accounting principles utilized in the United States, or GAAP, in this release, including the Financial Ratios and Other Data contains non-GAAP financial measures. Non-GAAP financial measures include: 1) core efficiency ratio, 2) tangible book value per share and 3) tangible common equity to tangible assets. The Company uses these non-GAAP financial measures to provide meaningful supplemental information regarding the Company’s operational performance, performance trends and financial condition, and to enhance investors’ overall understanding of such financial performance. In particular, the use of tangible book value per share and tangible common equity to tangible assets is prevalent among banking regulators, investors and analysts.

    The numerator for the core efficiency ratio is calculated by subtracting acquisition costs and intangible asset amortization from noninterest expense. Tangible assets and tangible common shareholders’ equity are calculated by excluding intangible assets from assets and shareholders’ equity, respectively. For these financial measures, our intangible assets consist of goodwill and core deposit intangible. Tangible book value per share is calculated by dividing tangible common shareholders’ equity by the number of common shares outstanding. We believe that this measure is consistent with the capital treatment by our bank regulatory agencies, which exclude intangible assets from the calculation of risk-based capital ratios and present this measure to facilitate the comparison of the quality and composition of our capital over time and in comparison, to our competitors.

    Non-GAAP financial measures have inherent limitations, are not required to be uniformly applied, and are not audited. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures with other companies’ non-GAAP financial measures having the same or similar names. Further, the non-GAAP financial measure of tangible book value per share should not be considered in isolation or as a substitute for book value per share or total shareholders’ equity determined in accordance with GAAP, and may not be comparable to a similarly titled measure reported by other companies. Eagle strongly encourages investors to review its consolidated financial statements in their entirety and not to rely on any single financial measure. Reconciliation of the GAAP and non-GAAP financial measures are presented below.

    Balance Sheet      
    (Dollars in thousands, except per share data)   (Unaudited)  
      December 31, September 30, December 31,
      2024 2024 2023
           
    Assets:      
    Cash and due from banks $ 29,824   $ 22,954   $ 23,243  
    Interest bearing deposits in banks   1,735     19,035     1,302  
    Federal funds sold   –     200     –  
    Total cash and cash equivalents   31,559     42,189     24,545  
    Securities available-for-sale, at fair value   292,590     306,982     318,279  
    Federal Home Loan Bank (“FHLB”) stock   7,778     11,218     9,191  
    Federal Reserve Bank (“FRB”) stock   4,131     4,131     4,131  
    Mortgage loans held-for-sale, at fair value   13,368     13,429     11,432  
    Loans:      
    Real estate loans:      
    Residential 1-4 family   153,721     156,811     156,578  
    Residential 1-4 family construction   45,701     52,217     43,434  
    Commercial real estate   645,962     644,019     608,691  
    Commercial construction and development   124,211     125,323     158,132  
    Farmland   146,610     145,356     142,590  
    Other loans:      
    Home equity   97,543     93,646     86,932  
    Consumer   28,513     29,445     30,125  
    Commercial   144,039     143,190     132,709  
    Agricultural   134,346     144,645     125,298  
    Total loans   1,520,646     1,534,652     1,484,489  
    Allowance for credit losses   (16,850 )   (17,130 )   (16,440 )
    Net loans   1,503,796     1,517,522     1,468,049  
    Accrued interest and dividends receivable   12,890     14,844     12,485  
    Mortgage servicing rights, net   15,376     15,443     15,853  
    Assets held-for-sale, at cost   960     257     –  
    Premises and equipment, net   101,540     100,297     94,282  
    Cash surrender value of life insurance, net   53,232     52,852     47,939  
    Goodwill   34,740     34,740     34,740  
    Core deposit intangible, net   4,499     4,834     5,880  
    Other assets   26,631     26,375     28,860  
    Total assets $ 2,103,090   $ 2,145,113   $ 2,075,666  
           
    Liabilities:      
    Deposit accounts:      
    Noninterest bearing $ 419,211   $ 419,760   $ 418,727  
    Interest bearing   1,262,017     1,230,752     1,216,468  
    Total deposits   1,681,228     1,650,512     1,635,195  
    Accrued expenses and other liabilities   47,018     38,593     36,462  
    FHLB advances and other borrowings   140,930     219,167     175,737  
    Other long-term debt, net   59,149     59,111     58,999  
    Total liabilities   1,928,325     1,967,383     1,906,393  
           
    Shareholders’ Equity:      
    Preferred stock (par value $0.01 per share; 1,000,000 shares      
    authorized; no shares issued or outstanding)   –     –     –  
    Common stock (par value $0.01; 20,000,000 shares authorized;      
    8,507,429 shares issued; 8,027,177, 8,016,784 and 8,016,784      
    shares outstanding at December 31, 2024, September 30, 2024, and      
    December 31, 2023, respectively   85     85     85  
    Additional paid-in capital   108,334     109,040     108,819  
    Unallocated common stock held by Employee Stock Ownership Plan   (4,011 )   (4,154 )   (4,583 )
    Treasury stock, at cost (480,252, 490,645 and 490,645 shares at      
    December 31, 2024, September 30, 2024, and December 31, 2023, respectively)   (10,761 )   (11,124 )   (11,124 )
    Retained earnings   101,264     98,979     96,021  
    Accumulated other comprehensive loss, net of tax   (20,146 )   (15,096 )   (19,945 )
    Total shareholders’ equity   174,765     177,730     169,273  
    Total liabilities and shareholders’ equity $ 2,103,090   $ 2,145,113   $ 2,075,666  
           
    Income Statement   (Unaudited)     (Unaudited)
    (Dollars in thousands, except per share data) Three Months Ended   Years Ended
      December 31, September 30, December 31,   December 31,
      2024 2024 2023   2024 2023
    Interest and dividend income:            
    Interest and fees on loans $ 23,756   $ 23,802   $ 21,481     $ 92,282   $ 79,423  
    Securities available-for-sale   2,475     2,598     2,790       10,428     11,376  
    FRB and FHLB dividends   308     266     247       1,085     727  
    Other interest income   148     94     23       416     89  
    Total interest and dividend income   26,687     26,760     24,541       104,211     91,615  
    Interest expense:            
    Interest expense on deposits   7,216     7,190     6,090       27,838     17,857  
    FHLB advances and other borrowings   2,005     3,084     2,569       10,211     8,562  
    Other long-term debt   676     684     684       2,724     2,719  
    Total interest expense   9,897     10,958     9,343       40,773     29,138  
    Net interest income   16,790     15,802     15,198       63,438     62,477  
    (Recapture) provision for credit losses   (36 )   277     270       518     1,456  
    Net interest income after provision for credit losses   16,826     15,525     14,928       62,920     61,021  
                 
    Noninterest income:            
    Service charges on deposit accounts   387     430     444       1,645     1,757  
    Mortgage banking, net   2,818     2,602     3,718       10,014     14,970  
    Interchange and ATM fees   675     662     663       2,540     2,524  
    Appreciation in cash surrender value of life insurance   408     1,038     301       2,054     1,466  
    Net loss on sale of available-for-sale securities   (141 )   –     –       (141 )   (222 )
    Other noninterest income   425     251     686       1,664     2,227  
    Total noninterest income   4,572     4,983     5,812       17,776     22,722  
                 
    Noninterest expense:            
    Salaries and employee benefits   9,830     9,894     11,359       39,715     42,973  
    Occupancy and equipment expense   2,194     2,134     1,972       8,531     8,072  
    Data processing   1,715     1,587     1,673       6,209     5,943  
    Software subscriptions   576     511     519       2,127     2,064  
    Advertising   466     277     445       1,312     1,375  
    Amortization   337     337     386       1,391     1,587  
    Loan costs   372     385     461       1,567     1,887  
    FDIC insurance premiums   287     295     288       1,165     1,150  
    Professional and examination fees   596     438     438       1,941     1,922  
    Other noninterest expense   1,323     1,412     1,350       5,348     5,116  
    Total noninterest expense   17,696     17,270     18,891       69,306     72,089  
                 
    Income before provision for income taxes   3,702     3,238     1,849       11,390     11,654  
    Provision (benefit) for income taxes   269     529     (315 )     1,612     1,598  
    Net income $ 3,433   $ 2,709   $ 2,164     $ 9,778   $ 10,056  
                 
    Basic earnings per common share $ 0.44   $ 0.35   $ 0.28     $ 1.25   $ 1.29  
    Diluted earnings per common share $ 0.44   $ 0.34   $ 0.28     $ 1.24   $ 1.29  
                 
    Basic weighted average shares outstanding   7,862,279     7,836,921     7,809,274       7,838,822     7,793,352  
                 
    Diluted weighted average shares outstanding   7,868,507     7,860,138     7,815,022       7,853,792     7,798,244  
                 
    ADDITIONAL FINANCIAL INFORMATION   (Unaudited)  
    (Dollars in thousands, except per share data) Three Months Ended or Years Ended
      December 31, September 30, December 31,
      2024 2024 2023
           
    Mortgage Banking Activity (For the quarter):      
    Net gain on sale of mortgage loans $ 2,036   $ 1,691   $ 2,845  
    Net change in fair value of loans held-for-sale and derivatives   (3 )   159     (40 )
    Mortgage servicing income, net   785     752     913  
    Mortgage banking, net $ 2,818   $ 2,602   $ 3,718  
           
    Mortgage Banking Activity (Year-to-date):      
    Net gain on sale of mortgage loans $ 6,741     $ 11,396  
    Net change in fair value of loans held-for-sale and derivatives   (5 )     194  
    Mortgage servicing income, net   3,278       3,380  
    Mortgage banking, net $ 10,014     $ 14,970  
           
    Performance Ratios (For the quarter):      
    Return on average assets   0.65%   0.51%   0.42%
    Return on average equity   8.12%   6.56%   5.68%
    Yield on average interest earning assets   5.70%   5.66%   5.36%
    Cost of funds   2.69%   2.89%   2.58%
    Net interest margin   3.59%   3.34%   3.32%
    Core efficiency ratio*   81.26%   81.47%   88.08%
           
    Performance Ratios (Year-to-date):      
    Return on average assets   0.47%     0.50%
    Return on average equity   5.94%     6.33%
    Yield on average interest earning assets   5.62%     5.14%
    Cost of funds   2.76%     2.11%
    Net interest margin   3.42%     3.51%
    Core efficiency ratio*   83.62%     82.75%
           
    * The core efficiency ratio is a non-GAAP ratio that is calculated by dividing non-interest expense, exclusive of acquisition
    costs and intangible asset amortization, by the sum of net interest income and non-interest income.    
           
           
           
    ADDITIONAL FINANCIAL INFORMATION      
    (Dollars in thousands, except per share data)      
           
    Asset Quality Ratios and Data: As of or for the Three Months Ended
      December 31, September 30, December 31,
      2024 2024 2023
           
    Nonaccrual loans $ 3,227   $ 3,859   $ 8,395  
    Loans 90 days past due and still accruing   623     944     26  
    Total nonperforming loans   3,850     4,803     8,421  
    Other real estate owned and other repossessed assets   45     4     5  
    Total nonperforming assets $ 3,895   $ 4,807   $ 8,426  
           
    Nonperforming loans / portfolio loans   0.25%   0.31%   0.57%
    Nonperforming assets / assets   0.19%   0.22%   0.41%
    Allowance for credit losses / portfolio loans   1.11%   1.12%   1.11%
    Allowance for credit losses/ nonperforming loans   437.66%   356.65%   195.23%
    Gross loan charge-offs for the quarter $ 51   $ 22   $ 11  
    Gross loan recoveries for the quarter $ 7   $ 5   $ 1  
    Net loan charge-offs for the quarter $ 44   $ 17   $ 10  
           
           
      December 31, September 30, December 31,
      2024 2024 2023
    Capital Data (At quarter end):      
    Common shareholders’ equity (book value) per share $ 21.77   $ 22.17   $ 21.11  
    Tangible book value per share** $ 16.88   $ 17.23   $ 16.05  
    Shares outstanding   8,027,177     8,016,784     8,016,784  
    Tangible common equity to tangible assets***   6.57%   6.56%   6.32%
           
    Other Information:      
    Average investment securities for the quarter $ 300,088   $ 305,730   $ 306,678  
    Average investment securities year-to-date $ 306,538   $ 308,688   $ 328,533  
    Average loans for the quarter **** $ 1,533,686   $ 1,547,246   $ 1,494,181  
    Average loans year-to-date **** $ 1,523,384   $ 1,519,951   $ 1,436,672  
    Average earning assets for the quarter $ 1,858,078   $ 1,874,669   $ 1,817,419  
    Average earning assets year-to-date $ 1,850,120   $ 1,847,468   $ 1,780,727  
    Average total assets for the quarter $ 2,107,357   $ 2,116,839   $ 2,062,267  
    Average total assets year-to-date $ 2,092,051   $ 2,086,951   $ 2,015,586  
    Average deposits for the quarter $ 1,671,653   $ 1,622,254   $ 1,626,598  
    Average deposits year-to-date $ 1,636,390   $ 1,624,636   $ 1,603,861  
    Average equity for the quarter $ 169,054   $ 165,162   $ 152,516  
    Average equity year-to-date $ 164,591   $ 163,106   $ 158,807  
           
           
           
    ** The tangible book value per share is a non-GAAP ratio that is calculated by dividing shareholders’ equity,
    less goodwill and core deposit intangible, by common shares outstanding.
    *** The tangible common equity to tangible assets is a non-GAAP ratio that is calculated by dividing shareholders’
    equity, less goodwill and core deposit intangible, by total assets, less goodwill and core deposit intangible.
    **** Includes loans held for sale
    Reconciliation of Non-GAAP Financial Measures          
                 
    Core Efficiency Ratio   (Unaudited)     (Unaudited)
    (Dollars in thousands) Three Months Ended   Years Ended
      December 31, September 30, December 31,   December 31,
      2024 2024 2023   2024 2023
    Calculation of Core Efficiency Ratio:            
    Noninterest expense $ 17,696   $ 17,270   $ 18,891     $ 69,306   $ 72,089  
    Intangible asset amortization   (337 )   (337 )   (386 )     (1,391 )   (1,587 )
    Core efficiency ratio numerator   17,359     16,933     18,505       67,915     70,502  
                 
    Net interest income   16,790     15,802     15,198       63,438     62,477  
    Noninterest income   4,572     4,983     5,812       17,776     22,722  
    Core efficiency ratio denominator   21,362     20,785     21,010       81,214     85,199  
                 
    Core efficiency ratio (non-GAAP)   81.26%   81.47%   88.08%     83.62%   82.75%
                 
    Tangible Book Value and Tangible Assets (Unaudited)
    (Dollars in thousands, except per share data) December 31, September 30, December 31,
      2024 2024 2023
    Tangible Book Value:      
    Shareholders’ equity $ 174,765   $ 177,730   $ 169,273  
    Goodwill and core deposit intangible, net   (39,239 )   (39,574 ) $ (40,620 )
    Tangible common shareholders’ equity (non-GAAP) $ 135,526   $ 138,156   $ 128,653  
           
    Common shares outstanding at end of period   8,027,177     8,016,784     8,016,784  
           
    Common shareholders’ equity (book value) per share (GAAP) $ 21.77   $ 22.17   $ 21.11  
           
    Tangible common shareholders’ equity (tangible book value)      
    per share (non-GAAP) $ 16.88   $ 17.23   $ 16.05  
           
    Tangible Assets:      
    Total assets $ 2,103,090   $ 2,145,113   $ 2,075,666  
    Goodwill and core deposit intangible, net   (39,239 )   (39,574 )   (40,620 )
    Tangible assets (non-GAAP) $ 2,063,851   $ 2,105,539   $ 2,035,046  
           
    Tangible common shareholders’ equity to tangible assets      
    (non-GAAP)   6.57%   6.56%   6.32%
           
    Contacts: Laura F. Clark, President and CEO
    (406) 457-4007
    Miranda J. Spaulding, SVP and CFO
    (406) 441-5010
       

    The MIL Network –

  • MIL-OSI Global: Engineering the social: Students in this course use systems thinking to help solve human rights, disease and homelessness

    Source: The Conversation – USA – By Raúl Ordóñez, Professor of Electrical and Computer Engineering, University of Dayton

    An engineering education can equip students to work on broader social issues. Photosomnia/E+ via Getty Images

    Uncommon Courses is an occasional series from The Conversation U.S. highlighting unconventional approaches to teaching.

    Title of course:

    Engineering Systems for the Common Good

    What prompted the idea for the course?

    As a control systems researcher, I have long felt that control systems – and systems science in general – have much to contribute to solving social problems.

    Control systems make other systems behave in some desired manner. Think of the cruise control in a car, which keeps its speed constant, or the thermostat in a house that regulates temperature.

    I wanted to know whether engineers could treat society and social phenomena as systems in the engineering sense. That way, students and researchers could mathematically model and even simulate these phenomena using computers.

    Control systems engineering offers a set of powerful analysis and design tools. I wanted to know whether my students and I could apply these methods to things such as policymaking to help address societal problems.

    What does the course explore?

    In this course, students learn fundamental systems theory concepts, such as block diagrams, feedback loops and discrete-time dynamics. They apply these concepts to mathematically model and analyze social systems.

    In the class, I talk with the students about human rights. We think about how this powerful idea applies to social systems. This systems framework helps us approach social justice issues in a methodical, mathematical manner.

    In Raúl Ordóñez’s class at the University of Dayton, students take engineering concepts and apply them to societal issues.
    Shawn Robinson/University of Dayton

    Students use simulation software to model systems such as disease epidemics, the viral spread of ideas, the tragedy of the commons and homelessness, among others.

    Importantly, they learn that some social phenomena can be methodically studied and engineered, in a quantifiable manner. For example, they can use numbers and data to experiment and evaluate how introducing vaccines affects disease spread.

    By the end of the course, students gain a deeper understanding of the connection between engineering principles and tools and human rights and society.

    Why is this course relevant now?

    This course helps bridge the gap between engineering and social sciences by bringing concepts from human rights and social justice to engineering students. It teaches them how the powerful engineering tools they learn throughout the engineering curriculum can directly serve the common good.

    What’s a critical lesson from the course?

    The course is a concrete step toward teaching engineering and science students that engineering has more to offer to society than its direct applications. Students learn that a partnership between the humanities and engineering is not only possible but strongly desirable for the advancement of the common good.

    What materials does the course feature?

    There is no one textbook that deals with all the topics in this course, although the book “Humanitarian Engineering: Advancing Technology for Sustainable Development,” third edition, by Kevin M. Passino, is a very useful resource. I have mostly developed my own materials, including my set of lecture notes, projects and numerical simulation code.

    Many engineers use tools in engineering to help people and communities.

    What will the course prepare students to do?

    The course aims to prepare students to apply common engineering tools such as differential equations, signals and systems, systems analysis, mathematical models and numerical simulation to the analysis of social problems, with an emphasis on human rights implications.

    It also introduces social modeling as a powerful method for understanding social issues and assessing how various policies affect human rights.

    My goal is to produce engineering students who can meaningfully contribute to policymaking by using engineering tools to assess the consequences of social and economic policies.

    Dr. Kevin M. Passino was my doctoral research adviser at the Ohio State University, where I did my PhD.

    – ref. Engineering the social: Students in this course use systems thinking to help solve human rights, disease and homelessness – https://theconversation.com/engineering-the-social-students-in-this-course-use-systems-thinking-to-help-solve-human-rights-disease-and-homelessness-242893

    MIL OSI – Global Reports –

  • MIL-OSI Global: Nutrition advice is rife with misinformation − a medical education specialist explains how to tell valid health information from pseudoscience

    Source: The Conversation – USA – By Aimee Pugh Bernard, Assistant Professor of Immunology and Microbiology, University of Colorado Anschutz Medical Campus

    If a health claim about a dietary intervention sounds too good to be true, it probably is.
     Mizina/iStock via Getty Images Plus

    The COVID-19 pandemic illuminated a vast landscape of misinformation about many topics, science and health chief among them.

    Since then, information overload continues unabated, and many people are rightfully confused by an onslaught of conflicting health information. Even expert advice is often contradictory.

    On top of that, people sometimes deliberately distort research findings to promote a certain agenda. For example, trisodium phosphate is a common food additive in cakes and cookies that is used to improve texture and prevent spoilage, but wellness influencers exploit the fact that a similarly named substance is used in paint and cleaning products to suggest it’s dangerous to your health.

    Such claims can proliferate quickly, creating widespread misconceptions and undermining trust in legitimate scientific research and medical advice. Social media’s rise as a news and information source further fuels the spread of pseudoscientific views.

    Misinformation is rampant in the realm of health and nutrition. Findings from nutrition research is rarely clear-cut because diet is just one of many behaviors and lifestyle factors affecting health, but the simplicity of using food and supplements as a cure-all is especially seductive.

    I am an assistant professor specializing in medical education and science communication. I also train scientists and future health care professionals how to communicate their science to the general public.

    In my view, countering the voices of social media influencers and health activists promoting pseudoscientific health claims requires leaning into the science of disease prevention. Extensive research has produced a body of evidence-based practices and public health measures that have consistently been shown to improve the health of millions of people around the world. Evaluating popular health claims against the yardstick of this work can help distinguish which ones are based on sound science.

    To parse pseudoscientific claims from sound advice about health and nutrition, it’s crucial to evaluate the information’s source.
    tadamichi/Getty Images

    Navigating the terrain of tangled information

    Conflicting information can be found on just about everything we eat and drink.

    That’s because a food or beverage is rarely just good or bad. Instead, its health effects can depend on everything from the quantity a person consumes to their genetic makeup. Hundreds of scientific studies describe coffee’s health benefits and, on the flip side, its health risks. A bird’s-eye view can point in one direction or another, but news articles and social media posts often make claims based on a single study.

    Things can get even more confusing with dietary supplements because people who promote them often make big claims about their health benefits. Take apple cider vinegar, for example – or ACV, if you’re in the know.

    Apple cider vinegar has been touted as an all-natural remedy for a variety of ailments, including digestive issues, urinary health and weight management. Indeed, some studies have shown that it might help lower cholesterol, in addition to having other health benefits, but overall those studies have small sample sizes and are inconclusive.

    Advocates of this substance often claim that one particular component of it – the cloudy sediment at the bottom of the bottle termed “the mother” – is especially beneficial because of the bacteria and yeast it contains. But there is no research that backs the claim that it offers any health benefits.

    One good rule of thumb is that health hacks that promise quick fixes are almost always too good to be true. And even when supplements do offer some health benefits under specific circumstances, it’s important to remember that they are largely exempt from Food and Drug Administration regulations. That means the ingredients on their labels might contain more or less of the ingredients promised or other ingredients not listed, which can potentially cause harms such as liver toxicity.

    It’s also important to keep in mind that the global dietary supplements industry is worth more than US$150 billion per year, so companies – and wellness influencers – selling supplements have a financial stake in convincing the public of their value.

    Misinformation about nutrition is nothing new, but that doesn’t make it any less confusing.

    How nutrition science gets twisted

    There’s no doubt that good nutrition is fundamental for your health. Studies consistently show that a balanced diet containing a variety of essential nutrients can help prevent chronic diseases and promote overall well-being.

    For instance, minerals such as calcium and iron support bone health and oxygen circulation in the blood, respectively. Proteins are essential for muscle repair and growth, and healthy fats, like those found in avocados and nuts, are vital for brain health.

    However, pseudoscientific claims often twist such basic facts to promote the idea that specific diets or supplements can prevent or treat illness. For example, vitamin C is known to play a role in supporting the immune system and can help reduce the duration and severity of colds.

    But despite assertions to the contrary, consuming large quantities of vitamin C does not prevent colds. In fact, the body needs only a certain amount of vitamin C to function properly, and any excess is simply excreted.

    Companies sometimes claim their supplement is “scientifically proven” to cure illness or boost brain function, with no credible research to back it up.

    Some companies overstate the benefits while underplaying the hazards.

    For example, wellness influencers have promoted raw milk over pasteurized milk as a more natural and nutritious choice, but consuming it is risky. Unpasteurized milk can contain harmful bacteria that leads to gastrointestinal illness and, in some cases, much more serious and potentially life-threatening diseases such as avian influenza, or bird flu.

    Such dietary myths aren’t harmless. Reliance on nutrition alone can lead to neglecting other critical aspects of health, such as regular medical checkups and lifesaving vaccinations.

    The lure of dietary myths has led people with cancer to replace proven science-backed treatments, such as chemotherapy or radiation, with unproven and misleading nutrition programs.

    How to spot less-than-solid science

    Pseudoscience exploits your insecurities and emotions, taking advantage of your desire to live the healthiest life possible.

    While the world around you may be uncertain and out of your control, you want to believe that at the very least, you have control over your own health. This is where the wellness industry steps in.

    What makes pseudoscientific claims so confusing is that they use just enough scientific jargon to sound believable. Supplements or powders that claim to “boost immunity” often list ingredients such as adaptogens and superfoods. While these words sound real and convincing, they actually don’t mean anything in science. They are terms created by the wellness industry to sell products.

    I’ve researched and written about reliable ways to distinguish science facts from false health claims. To stay alert and find credible information, I’d suggest you follow a few key steps.

    First, check your emotions – strong emotional reactions, such as fear and anger, can be a red flag.

    Next, check that the author has experience or expertise in the field of the topic. If they’re not an expert, they might not know what they are talking about. It’s always a good idea to make sure the source is reputable – ask yourself, would this source be trusted by scientists?

    Finally, search for references that back up the information. If very little or nothing else exists in the science world to back up the claims, you may want to put your trust in a different source.

    Following these steps will separate the facts from fake news and empower you to make evidence-based decisions.

    Aimee Pugh Bernard is an unpaid board member for Immunize Colorado

    – ref. Nutrition advice is rife with misinformation − a medical education specialist explains how to tell valid health information from pseudoscience – https://theconversation.com/nutrition-advice-is-rife-with-misinformation-a-medical-education-specialist-explains-how-to-tell-valid-health-information-from-pseudoscience-246478

    MIL OSI – Global Reports –

  • MIL-OSI United Kingdom: New humanitarian support for Gaza as ceasefire allows operations to scale up

    Source: United Kingdom – Government Statements

    The Minister for Development announces new £17 million package to support thousands of civilians across the Occupied Palestinian Territories.

    • UK aid package will ensure healthcare, food and shelter reaches tens of thousands of civilians and supports vital infrastructure across the Occupied Palestinian Territories.

    • Minister for Development, Anneliese Dodds announces £17 million package and reiterates need for much more aid to enter Gaza with the support of UN agencies including UNRWA.

    • Comes as 300,000 people now confirmed treated by UK-Med at field hospitals in Gaza thanks to UK funding.

    Thousands of civilians in Gaza will receive humanitarian aid funded by the UK.

    Food assistance programmes, water and sanitation services and maternal and children’s healthcare are some of the areas which will be scaled up with new funding.

    This will build on UK efforts over the past 15 months which have ensured more than half a million people have received essential healthcare in Gaza.  

    Within this £17 million package announced today, £2 million in funding for the World Bank will support critical water and energy infrastructure construction and restoration across the Occupied Palestinian Territories (OPTs), including in Gaza. The UK’s ongoing support has meant 284,000 people in Gaza already have improved access to water, sanitation and hygiene services. 

    This announcement brings the total UK support for the OPTs this financial year to £129 million, demonstrating the UK’s commitment to playing a leading role in alleviating Palestinian suffering and helping to build security and economic recovery in the Middle East. This will help drive UK security, in support of the Government’s Plan for Change. 

    It comes as a Jordanian-led helicopter initiative flying aid directly to Gaza has started delivering lifesaving UK-funded medicines to civilians today. As well as providing up to £500,000 of supplies onboard, the UK has also deployed military planners to assist with logistics. Speaking in the House this afternoon, Minister Dodds will underscore the UK’s pride in working with Jordan – who have demonstrated leadership and commitment to deliver aid via all routes possible – to get the airbridge up and running in such challenging circumstances.

    Minister for Development Anneliese Dodds said: 

    The scale of suffering in Gaza cannot be overstated and the UN and its agencies, including UNRWA, must be allowed by Israel to do their vital work.  

    This announcement is part of the UK’s investment in the ceasefire deal, scaling up aid operations and helping the most desperate people access healthcare, water, food and shelter.  

    We must seize this opportunity to get a surge of humanitarian aid to Gaza, all the hostages released and a path towards a viable Palestinian state.

    Minister Dodds emphasised the UK will also continue to support the crucial role played by UN agencies and NGOs operating in Gaza. This includes UNRWA, which has played a vital role in the increase in humanitarian assistance since the ceasefire earlier this month.

    Ahead of the upcoming implementation of Israel’s UNRWA legislation on 30 January, which risks jeopardising the humanitarian response in Gaza and the delivery of essential services in East Jerusalem and the West Bank, the UK has urged Israel to ensure that UNRWA can continue its lifesaving operations for Palestinian refugees. Israel has a responsibility under international law to facilitate humanitarian assistance. Minister Dodds will again reiterate that humanitarian operations must not face a cliff edge on 30 January.

    The Minister for Development also confirmed that the UK provided an additional £4.5 million to UK-Med last year. The charity deploys staff, many of whom work in the NHS, to crisis-hit areas around the world to deliver life and limb-saving healthcare. NHS staff who work for UK-Med typically deploy to Gaza for a four-week period, supporting lifesaving efforts and gaining essential trauma experience.

    UK funding has helped doctors in Gaza treat more than 300,000 patients in Gaza with a range of medical conditions as well as treating injuries directly associated with the conflict. This funding is on top of the £5.5 million announced for the charity on the Foreign Secretary’s first visit to Israel and the OPTs in July last year. 

    UK-Med CEO, David Wightwick said:

    After more than two decades in humanitarian work, I have never seen a crisis of this scale and severity.

    That’s why UK Government funding is vital in providing support to UK-Med to deliver life-saving care to over 300,000 patients in Gaza during 2024. 

    I want to thank our 400-strong team on the ground for their determination, professionalism and tireless work to address the health impacts of this devastating conflict.

    This government’s steadfast support for UNRWA, including £41m of support this financial year, has helped the organisation deliver its humanitarian operation and provide essential services such as education, social care and vaccinations across the OPTs and to Palestinian refugees in the region.  

    Notes to editors 

    • The £17 million package announced today consists of: 
    • £15 million of UK funding comes from the Crisis Reserve pool to be allocated to partner agencies. 
    • £2 million of funding for the World Bank to deliver water and energy infrastructure across the OPTs, including in Gaza 
    • An additional £4.5 million of funding to UK-Med has previously been allocated and spent but not announced  
    • UK-Med operate two field hospitals in Gaza, Deir Al Balah and Al Mawasi. The Al Mawasi field hospital has, among other facilities, an operating theatre, a maternity unit and physical rehabilitation services for patients. At Deir Al Balah, UK-Med staff deliver primary care and see over 400 patients a day.  *This air bridge to Gaza is no substitute for the road routes. The terms of the ceasefire must be adhered to, so that many more trucks can safely and effectively distribute aid within Gaza.
    • Footage – b-roll of UK aid to Gaza via Jordanian helicopters and UK-Med field hospital

    Media enquiries

    Email newsdesk@fcdo.gov.uk

    Telephone 020 7008 3100

    Contact the FCDO Communication Team via email (monitored 24 hours a day) in the first instance, and we will respond as soon as possible.

    Updates to this page

    Published 28 January 2025

    MIL OSI United Kingdom –

  • MIL-OSI Asia-Pac: CHP receives three severe cases of influenza A infection in one day

    Source: Hong Kong Government special administrative region

    CHP receives three severe cases of influenza A infection in one day
    CHP receives three severe cases of influenza A infection in one day
    *******************************************************************

         Following a severe case of influenza A infection in a 10-month-old baby girl who had not received seasonal influenza vaccination (SIV) yesterday (January 27), the Centre for Health Protection (CHP) of the Department of Health (DH) today (January 28) received two more cases of severe paediatric influenza A infection in children who have not yet received the SIV. Another severe paediatric case of co-infection with influenza A and group A streptococcus was also reported.           The first case involved a six-year-old boy with good past health, who developed fever on January 26. He attended the Union Hospital yesterday and was later transferred to Prince of Wales Hospital, where he remains in the paediatric intensive care unit. His nasopharyngeal swab specimen tested positive for influenza A (H1) virus upon laboratory testing. The clinical diagnosis was influenza A infection complicated with shock. So far, his household contacts show no upper respiratory symptom and there has been no recent influenza outbreak at his school.           The second case involved a twelve-year-old boy with underlying illness who developed fever and cough yesterday. He was admitted to Tuen Mun Hospital today, where he remains in the paediatric intensive care unit. His nasopharyngeal swab specimen tested positive for influenza A (H3) virus upon laboratory testing. The clinical diagnosis was influenza A infection complicated with severe pneumonia and shock. He lives in a school dormitory and seven other students from the same school have recently developed upper respiratory symptoms. The CHP had conducted inspection at the school and provided health advice.           “The above-mentioned two boys had no travel history during the incubation period. An initial investigation revealed that they did not receive 2024/25 SIV. The CHP reiterated its call to the parents to bring their children to receive SIV as soon as possible,” a spokesman for the CHP said.           Furthermore, an eight-year-old boy with good past health developed fever since January 23, and cough and shortness of breath since yesterday. He was admitted to the Princess Margaret Hospital on the same day, where he remains in the paediatric intensive care unit. His nasopharyngeal swab specimen tested positive for influenza A (H1) virus and his blood sample tested positive for group A streptococcus. The clinical diagnosis was co-infection with influenza A and group A streptococcus complicated with sepsis.           “Since the start of this influenza season in early January, the CHP has recorded eight cases (including three above-mentioned children) of severe influenza virus infection in children. Six of them were unvaccinated. Influenza vaccination has been scientifically proven to be one of the most effective ways to prevent seasonal influenza and its complications, while significantly reducing the risk of hospitalisation and death from seasonal influenza. All persons aged 6 months and above (except those with known contraindications) who have not yet received SIV should act immediately, particularly the elderly and children who have a higher risk of becoming infected with influenza and developing complications,” he added.           Group A streptococcal infection is caused by bacteria, namely Streptococcus pyogenes, that can be found in the throat and on the skin. It can be transmitted by droplets and contact. The bacteria can cause mild diseases, including pharyngitis, impetigo and scarlet fever to invasive group A streptococcal infections (iGAS) such as necrotising fasciitis and streptococcal toxic shock syndrome. Anyone can get iGAS disease, but the elderly and young children, persons with chronic illnesses (e.g. diabetes) or immunocompromised persons may be at higher risk. People with breaks in the skin or with recent viral infections (e.g. chickenpox, influenza, etc.) are also at higher risk of developing iGAS disease. On the other hand, the disease can be effectively treated with antibiotics and prompt treatment helps alleviate symptoms faster and prevent complications.                     The spokesman reminded the public that Hong Kong has entered the influenza season. As the seasonal influenza activity is expected to increase further while the activity of other respiratory infectious diseases may also increase. To protect their health and that of their family members, the public should not only receive SIV, but also maintain good personal and environmental hygiene, and take the following measures to prevent contacting influenza, Group A streptococcal infection and other respiratory illnesses:      

    Wear surgical masks to prevent transmission of respiratory viruses from ill persons. It is essential for persons who are symptomatic (even if having mild symptoms) to wear a surgical mask;
    High-risk persons (e.g. persons with underlying medical conditions or persons who are immunocompromised) should wear surgical masks when visiting public places. The general public should also wear a surgical mask when taking public transport or staying in crowded places. It is important to wear a mask properly, including performing hand hygiene before wearing and after removing a mask;
    Avoid touching one’s eyes, mouth and nose;
    Practise hand hygiene frequently, wash hands with liquid soap and water properly whenever possibly contaminated;
    When hands are not visibly soiled, clean them with 70 to 80 per cent alcohol-based handrub;
    Cover the mouth and nose with tissue paper when sneezing or coughing. Dispose of soiled tissue paper properly into a lidded rubbish bin, and wash hands thoroughly afterwards;
    Practise good wound care to reduce the chance of getting infected;
    Maintain good indoor ventilation;
    Avoid sharing personal items;
    When having respiratory symptoms, wear a surgical mask, consider to refrain from going to work or school, avoid going to crowded places and seek medical advice promptly; and
    Maintain a balanced diet, perform physical activity regularly, take adequate rest, do not smoke and avoid overstress.

              ???For the latest information, members of the public can visit the CHP’s group A streptococcal infection and seasonal influenza webpages.

     
    Ends/Tuesday, January 28, 2025Issued at HKT 21:07

    NNNN

    MIL OSI Asia Pacific News –

  • MIL-OSI USA: Fact Sheet: President Donald J. Trump Reinstates Service Members Discharged for Refusing the COVID Vaccine

    US Senate News:

    Source: The White House
    RESINSTATING THE UNJUSTLY DISCHARGED: Today, President Donald J. Trump signed an Executive Order to reinstate service members who were dismissed for refusing the COVID vaccine, with full back pay and benefits.
    The Executive Order directs the Secretary of Defense to reinstate all members of the military (active and reserve) who were discharged for refusing the COVID vaccine and who request to be reinstated.
    Those who are reinstated will receive their former rank and full back pay with benefits.

    CORRECTING AN INJUSTICE: In spite of the scientific evidence, the Biden Administration discharged healthy service members—many of whom had natural immunity and dedicated their entire lives to serving our country—for refusing the COVID vaccine. Government redress of these wrongful dismissals is overdue.
    From 2021 to 2023, the Biden Administration and former Secretary of Defense Lloyd Austin discharged over 8,000 troops solely due to their COVID-19 vaccination status.
    Such dismissals likely had a chilling effect on recruitment, with the Department of Defense missing its collective recruiting targets by around 41,000 recruits in FY2023.
    After the vaccine mandate was repealed in 2023, only 43 of the more than the 8,000 troops dismissed elected to return to service under the Biden Administration and Secretary Austin.

    CHARTING A NEW COURSE FORWARD: In 2024, President Trump declared that “there should have never been a [COVID vaccine] mandate. That should have never happened.” 
    President Trump went on to lament that, due to the mandate, “we’ve lost some of our best people in the military too.”
    President Trump duly promised in 2024 that he “will rehire every patriot who was fired from the military with…backpay. They will get their backpay…”

    MIL OSI USA News –

  • MIL-OSI USA: Office of the Governor — News Release — Governor Green to Travel to Washington, D.C.

    Source: US State of Hawaii

    Office of the Governor — News Release — Governor Green to Travel to Washington, D.C.

    Posted on Jan 27, 2025 in Latest Department News, Newsroom, Office of the Governor Press Releases

    STATE OF HAWAIʻI 
    KA MOKU ʻĀINA O HAWAIʻI 
     
    JOSH GREEN, M.D. 
    GOVERNOR
    KE KIAʻĀINA 
     

    GOVERNOR GREEN TO TRAVEL TO WASHINGTON, D.C.
     

    FOR IMMEDIATE RELEASE
    January 27, 2025

    HONOLULU — Governor Josh Green, M.D., will travel to Washington, D.C., this week at the request of U.S. Senators and national health organizations to provide input regarding the nomination of Robert F. Kennedy Jr. for Secretary of Health and Human Services (HHS).

    Governor Green has expressed concerns about the potential impact of Kennedy’s confirmation on Hawai‘i and the nation, emphasizing the importance of a science-driven approach to public health.

    “Our people deserve a Health and Human Services Secretary who champions science, supports vaccines, and is committed to lowering costs while safeguarding health care access,” said Governor Green. “Mr. Kennedy’s lack of experience raises serious concerns about the future of critical programs like Medicare and Medicaid, which are lifelines for the people of Hawai‘i.”

    Drawing on his extensive background as an emergency room physician, longtime Legislator, Lieutenant Governor and Governor, Dr. Green will highlight the potential risks of this nomination, which has drawn criticism from leading public health experts. In 2019 as Hawai‘i’s Lieutenant Governor, Dr. Green played a pivotal role in addressing a severe measles epidemic in Samoa. His hands-on efforts, including vaccinating tens of thousands of individuals, demonstrated the lifesaving importance of science-based public health initiatives.

    The Governor will depart Hawai‘i on Monday evening, January 27, 2025, and return on Thursday afternoon, January 30, 2025. During his absence, Lieutenant Governor Sylvia Luke will serve as Acting Governor.

    # # # 

    Media Contacts:   
    Erika Engle
    Press Secretary
    Office of the Governor, State of Hawai‘i
    Phone: 808-586-0120
    Email: [email protected]

    Makana McClellan
    Director of Communications
    Office of the Governor, State of Hawaiʻi
    Cell: 808-265-0083
    Email: [email protected]

    MIL OSI USA News –

  • MIL-OSI USA News: Reinstating Service Members Discharged Under the Military’s COVID-19 Vaccination Mandate

    Source: The White House

    By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered:

    Section 1.  Purpose and Policy.  On August 24, 2021, the Secretary of Defense mandated that all service members receive the COVID-19 vaccine.  The Secretary of Defense later rescinded the mandate on January 10, 2023.  The vaccine mandate was an unfair, overbroad, and completely unnecessary burden on our service members.  Further, the military unjustly discharged those who refused the vaccine, regardless of the years of service given to our Nation, after failing to grant many of them an exemption that they should have received.  Federal Government redress of any wrongful dismissals is overdue. 

    Sec. 2.  Redress.  Consistent with the policies announced in section 1 of this order, the Secretary of Defense or the Secretary of Homeland Security, as appropriate, shall take all necessary action permitted by law to:

    (a)  make reinstatement available to all members of the military (active and reserve) who were discharged solely for refusal to receive the COVID-19 vaccine and who request to be reinstated;

    (b)  enable those service members reinstated under this section to revert to their former rank and receive full back pay, benefits, bonus payments, or compensation; and

    (c)  allow any service members who provide a written and sworn attestation that they voluntarily left the service or allowed their service to lapse according to appropriate procedures, rather than be vaccinated under the vaccine mandate, to return to service with no impact on their service status, rank, or pay.

    Sec. 3.  Additional Agency Responsibilities.  (a)  Nothing in this order precludes disciplinary or administrative action for conduct that is proscribed by chapter 47 of title 10, United States Code (Uniform Code of Military Justice, 10 U.S.C. 801-946a).

    (b)  Within 60 days of the date of this order, the Secretary of Defense and the Secretary of Homeland Security shall report to the President through the Assistant to the President for National Security Affairs on their progress in implementing this order.

    Sec. 4.  Severability.  If any provision of this order, or the application of any provision to any person or circumstance, is held to be invalid, the remainder of this order and the application of its provisions to any other persons or circumstances shall not be affected thereby.

    Sec. 5.  General Provisions.  (a)  Nothing in this order shall be construed to impair or otherwise affect:

    (i)   the authority granted by law to an executive department, agency, or the head thereof; or

    (ii)  the functions of the Director of the Office of Management and Budget relating to budgetary, administrative, or legislative proposals.

    (b)  This order shall be implemented consistent with applicable law and subject to the availability of appropriations.

    (c)  This order is not intended to, and does not, create any right or benefit, substantive or procedural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person.

    THE WHITE HOUSE,

        January 27, 2025.

    MIL OSI USA News –